{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:12:41Z","timestamp":1793506361009,"version":"4.5.0"},"reference-count":482,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1C1C1009000"],"award-info":[{"award-number":["NRF-2020R1C1C1009000"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","award":["20018522"],"award-info":[{"award-number":["20018522"]}],"id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00439394"],"award-info":[{"award-number":["RS-2024-00439394"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-026-01811-9","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:15:50Z","timestamp":1781079350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tumor microenvironment\u2013specific nanomedicine: from biology-driven to multi-omics\u2013guided precision engineering"],"prefix":"10.1186","volume":"19","author":[{"given":"Jee-Eun","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Jun","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"18","key":"1811_CR1","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res"},{"issue":"4","key":"1811_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jordao MJC, Joyce JA. Therapeutic Targeting of the Tumor Microenvironment. Cancer Discov. 2021;11(4):933\u201359.","journal-title":"Cancer Discov"},{"issue":"1","key":"1811_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"6","key":"1811_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41568-018-0006-7","volume":"18","author":"S Maman","year":"2018","unstructured":"Maman S, Witz IP. A history of exploring cancer in context. Nat Rev Cancer. 2018;18(6):359\u201376.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1811_CR5","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1021\/acs.molpharmaceut.5c00474","volume":"22","author":"X Yi","year":"2025","unstructured":"Yi X, Jin X, Hu Y, Shen Z, Zheng X, Luo D, Xu T, Yan J, Huang P. Drug Delivery Systems for Overcoming Physical Barriers in Cancer Therapy. Mol Pharm. 2025;22(11):6413\u201329.","journal-title":"Mol Pharm"},{"issue":"6769","key":"1811_CR6","doi-asserted-by":"publisher","first-page":"eadp7603","DOI":"10.1126\/science.adp7603","volume":"390","author":"S Groessl","year":"2025","unstructured":"Groessl S, Kalis R, Snaebjornsson MT, Wambach L, Haider J, Andersch F, Schulze A, Palm W, Zuber J. Acidosis orchestrates adaptations of energy metabolism in tumors. Science. 2025;390(6769):eadp7603.","journal-title":"Science"},{"key":"1811_CR7","doi-asserted-by":"crossref","unstructured":"Arlauckas SP, Garris CS, Kohler RH, Kitaoka M, Cuccarese MF, Yang KS, Miller MA, Carlson JC, Freeman GJ, Anthony RM et al. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med 2017, 9(389).","DOI":"10.1126\/scitranslmed.aal3604"},{"issue":"2","key":"1811_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono H, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201\u201318. e209.","journal-title":"Cancer Cell"},{"issue":"9","key":"1811_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17(9):527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1811_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The Microenvironmental Landscape of Brain Tumors. Cancer Cell. 2017;31(3):326\u201341.","journal-title":"Cancer Cell"},{"issue":"11","key":"1811_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"1811_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1811_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1811_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","volume":"24","author":"H Sabit","year":"2025","unstructured":"Sabit H, Pawlik TM, Radwan F, Abdel-Hakeem M, Abdel-Ghany S, Wadan AS, Elzawahri M, El-Hashash A, Arneth B. Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery. Mol Cancer. 2025;24(1):160.","journal-title":"Mol Cancer"},{"key":"1811_CR15","doi-asserted-by":"publisher","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","volume":"191","author":"R Sun","year":"2022","unstructured":"Sun R, Xiang J, Zhou Q, Piao Y, Tang J, Shao S, Zhou Z, Bae YH, Shen Y. The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. Adv Drug Deliv Rev. 2022;191:114614.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"1811_CR16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1039\/D1NA00810B","volume":"4","author":"MS Sudheesh","year":"2022","unstructured":"Sudheesh MS, Pavithran K. Revisiting the outstanding questions in cancer nanomedicine with a future outlook. Nanoscale Adv. 2022;4(3):634\u201353.","journal-title":"Nanoscale Adv"},{"issue":"1","key":"1811_CR17","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9(1):1410.","journal-title":"Nat Commun"},{"issue":"1","key":"1811_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting Strategies for Tissue-Specific Drug Delivery. Cell. 2020;181(1):151\u201367.","journal-title":"Cell"},{"key":"1811_CR19","doi-asserted-by":"publisher","first-page":"106087","DOI":"10.1016\/j.biocel.2021.106087","volume":"140","author":"MA Mansour","year":"2021","unstructured":"Mansour MA, Caputo VS, Aleem E. Highlights on selected growth factors and their receptors as promising anticancer drug targets. Int J Biochem Cell Biol. 2021;140:106087.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"1811_CR20","doi-asserted-by":"publisher","first-page":"e6800","DOI":"10.1002\/cam4.6800","volume":"13","author":"H Javid","year":"2024","unstructured":"Javid H, Oryani MA, Rezagholinejad N, Esparham A, Tajaldini M, Karimi-Shahri M. RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions. Cancer Med. 2024;13(2):e6800.","journal-title":"Cancer Med"},{"issue":"6","key":"1811_CR21","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s00259-024-06623-y","volume":"51","author":"K Liu","year":"2024","unstructured":"Liu K, Jiang T, Rao W, Chen B, Yin X, Xu P, Hu S. Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin alpha(v)beta(3). Eur J Nucl Med Mol Imaging. 2024;51(6):1544\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"40","key":"1811_CR22","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1002\/adma.201506312","volume":"28","author":"C Wang","year":"2016","unstructured":"Wang C, Sun W, Wright G, Wang AZ, Gu Z. Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody. Adv Mater. 2016;28(40):8912\u201320.","journal-title":"Adv Mater"},{"issue":"6","key":"1811_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","volume":"21","author":"EL Dane","year":"2022","unstructured":"Dane EL, Belessiotis-Richards A, Backlund C, Wang J, Hidaka K, Milling LE, Bhagchandani S, Melo MB, Wu S, Li N, et al. STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity. Nat Mater. 2022;21(6):710\u201320.","journal-title":"Nat Mater"},{"key":"1811_CR24","doi-asserted-by":"publisher","first-page":"855019","DOI":"10.3389\/fonc.2022.855019","volume":"12","author":"S Chu","year":"2022","unstructured":"Chu S, Shi X, Tian Y, Gao F. pH-Responsive Polymer Nanomaterials for Tumor Therapy. Front Oncol. 2022;12:855019.","journal-title":"Front Oncol"},{"issue":"55","key":"1811_CR25","doi-asserted-by":"publisher","first-page":"8492","DOI":"10.1039\/C6CC02972H","volume":"52","author":"T Thambi","year":"2016","unstructured":"Thambi T, Park JH, Lee DS. Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives. Chem Commun (Camb). 2016;52(55):8492\u2013500.","journal-title":"Chem Commun (Camb)"},{"key":"1811_CR26","doi-asserted-by":"publisher","first-page":"918789","DOI":"10.3389\/fmolb.2022.918789","volume":"9","author":"G Gonzalez-Avila","year":"2022","unstructured":"Gonzalez-Avila G, Sommer B, Garcia-Hernandez AA, Ramos C, Flores-Soto E. Nanotechnology and Matrix Metalloproteinases in Cancer Diagnosis and Treatment. Front Mol Biosci. 2022;9:918789.","journal-title":"Front Mol Biosci"},{"issue":"8","key":"1811_CR27","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1016\/j.apsb.2022.02.023","volume":"12","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Li S, Zhang S, Wang L, Yuan H, Hu F. Cell membrane coated-nanoparticles for cancer immunotherapy. Acta Pharm Sin B. 2022;12(8):3233\u201354.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1811_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5483\/BMBRep.2022.55.1.133","volume":"55","author":"SJ Choi","year":"2022","unstructured":"Choi SJ, Cho H, Yea K, Baek MC. Immune cell-derived small extracellular vesicles in cancer treatment. BMB Rep. 2022;55(1):48\u201356.","journal-title":"BMB Rep"},{"issue":"10","key":"1811_CR29","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1021\/acsnano.9b09713","volume":"14","author":"D Sun","year":"2020","unstructured":"Sun D, Zhou S, Gao W. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right. ACS Nano. 2020;14(10):12281\u201390.","journal-title":"ACS Nano"},{"key":"1811_CR30","doi-asserted-by":"crossref","unstructured":"Lammers T, Kiessling F, Ashford M, Hennink W, Crommelin D, Storm G. Cancer nanomedicine: Is targeting our target? Nat Rev Mater 2016, 1(9).","DOI":"10.1038\/natrevmats.2016.69"},{"issue":"1","key":"1811_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","volume":"6","author":"R Ge","year":"2022","unstructured":"Ge R, Wang Z, Cheng L. Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance. NPJ Precis Oncol. 2022;6(1):31.","journal-title":"NPJ Precis Oncol"},{"issue":"4","key":"1811_CR32","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.7150\/thno.38625","volume":"10","author":"JS de Maar","year":"2020","unstructured":"de Maar JS, Sofias AM, Porta Siegel T, Vreeken RJ, Moonen C, Bos C, Deckers R. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment. Theranostics. 2020;10(4):1884\u2013909.","journal-title":"Theranostics"},{"issue":"4","key":"1811_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s44222-024-00264-4","volume":"3","author":"Y Wang","year":"2025","unstructured":"Wang Y, Xiao Z, Wang Z, Lee D, Ma Y, Wilhelm S, Wang H, Kim BY, Jiang W. Multi-omics approaches to decipher the interactions of nanoparticles and biological systems. Nat Rev Bioeng. 2025;3(4):333\u201348.","journal-title":"Nat Rev Bioeng"},{"issue":"11","key":"1811_CR34","doi-asserted-by":"publisher","first-page":"e2201091","DOI":"10.1002\/smtd.202201091","volume":"6","author":"J Park","year":"2022","unstructured":"Park J, Choi J, Lee JE, Choi H, Im HJ. Spatial Transcriptomics-Based Identification of Molecular Markers for Nanomedicine Distribution in Tumor Tissue. Small Methods. 2022;6(11):e2201091.","journal-title":"Small Methods"},{"issue":"9","key":"1811_CR35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","volume":"18","author":"SM Lewis","year":"2021","unstructured":"Lewis SM, Asselin-Labat ML, Nguyen Q, Berthelet J, Tan X, Wimmer VC, Merino D, Rogers KL, Naik SH. Spatial omics and multiplexed imaging to explore cancer biology. Nat Methods. 2021;18(9):997\u20131012.","journal-title":"Nat Methods"},{"issue":"3","key":"1811_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792\u2013809. e723.","journal-title":"Cell"},{"issue":"8","key":"1811_CR37","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, Teinor JA, Belleau P, Biffi G, Lucito MS, et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"issue":"6294","key":"1811_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aaf2403","volume":"353","author":"PL Stahl","year":"2016","unstructured":"Stahl PL, Salmen F, Vickovic S, Lundmark A, Navarro JF, Magnusson J, Giacomello S, Asp M, Westholm JO, Huss M, et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353(6294):78\u201382.","journal-title":"Science"},{"issue":"6","key":"1811_CR39","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.08.043","volume":"182","author":"AL Ji","year":"2020","unstructured":"Ji AL, Rubin AJ, Thrane K, Jiang S, Reynolds DL, Meyers RM, Guo MG, George BM, Mollbrink A, Bergenstrahle J, et al. Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma. Cell. 2020;182(6):1661\u20132.","journal-title":"Cell"},{"issue":"3","key":"1811_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","volume":"38","author":"R Moncada","year":"2020","unstructured":"Moncada R, Barkley D, Wagner F, Chiodin M, Devlin JC, Baron M, Hajdu CH, Simeone DM, Yanai I. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas. Nat Biotechnol. 2020;38(3):333\u201342.","journal-title":"Nat Biotechnol"},{"key":"1811_CR41","doi-asserted-by":"publisher","first-page":"114992","DOI":"10.1016\/j.addr.2023.114992","volume":"200","author":"Y Abdelkader","year":"2023","unstructured":"Abdelkader Y, Perez-Davalos L, LeDuc R, Zahedi RP, Labouta HI. Omics approaches for the assessment of biological responses to nanoparticles. Adv Drug Deliv Rev. 2023;200:114992.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"1811_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, Satija R, Smibert P. Large-scale simultaneous measurement of epitopes and transcriptomes in single cells. Nat Methods. 2017;14(9):865.","journal-title":"Nat Methods"},{"issue":"1","key":"1811_CR43","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun C, Wang A, Zhou Y, Chen P, Wang X, Huang J, Gao J, Wang X, Shu L, Lu J, et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat Commun. 2023;14(1):2692.","journal-title":"Nat Commun"},{"issue":"6","key":"1811_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","volume":"40","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, Will P, Kueckelhaus J, Sun N, Joseph K, Salie H, Vollmer L, Kuliesiute U, von Ehr J, Benotmane JK, et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell. 2022;40(6):639\u201355. e613.","journal-title":"Cancer Cell"},{"key":"1811_CR45","doi-asserted-by":"publisher","first-page":"113786","DOI":"10.1016\/j.jconrel.2025.113786","volume":"383","author":"X Ding","year":"2025","unstructured":"Ding X, Liang Y, Zhou S, Wu Y, Salata P, Mikolajczk-Martinez A, Khosrawipour V, Zhang Z. Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance. J Control Release. 2025;383:113786.","journal-title":"J Control Release"},{"issue":"46","key":"1811_CR46","doi-asserted-by":"publisher","first-page":"32045","DOI":"10.1021\/acsnano.4c10381","volume":"18","author":"D Cahn","year":"2024","unstructured":"Cahn D, Stern A, Buckenmeyer M, Wolf M, Duncan GA. Extracellular Matrix Limits Nanoparticle Diffusion and Cellular Uptake in a Tissue-Specific Manner. ACS Nano. 2024;18(46):32045\u201355.","journal-title":"ACS Nano"},{"issue":"1","key":"1811_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41467-021-27667-w","volume":"13","author":"KHB Lam","year":"2022","unstructured":"Lam KHB, Leon AJ, Hui W, Lee SC, Batruch I, Faust K, Klekner A, Hutoczki G, Koritzinsky M, Richer M, et al. Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity. Nat Commun. 2022;13(1):116.","journal-title":"Nat Commun"},{"issue":"4","key":"1811_CR48","doi-asserted-by":"publisher","first-page":"zcae046","DOI":"10.1093\/narcan\/zcae046","volume":"6","author":"MJ Jimenez-Santos","year":"2024","unstructured":"Jimenez-Santos MJ, Garcia-Martin S, Rubio-Fernandez M, Gomez-Lopez G, Al-Shahrour F. Spatial transcriptomics in breast cancer reveals tumour microenvironment-driven drug responses and clonal therapeutic heterogeneity. NAR Cancer. 2024;6(4):zcae046.","journal-title":"NAR Cancer"},{"issue":"50","key":"1811_CR49","doi-asserted-by":"publisher","first-page":"e2409102","DOI":"10.1002\/adma.202409102","volume":"36","author":"L Qi","year":"2024","unstructured":"Qi L, Li Z, Liu J, Chen X. Omics-Enhanced Nanomedicine for Cancer Therapy. Adv Mater. 2024;36(50):e2409102.","journal-title":"Adv Mater"},{"issue":"1","key":"1811_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12672-025-04088-5","volume":"17","author":"L Yan","year":"2025","unstructured":"Yan L, Duan B, Wang T, Wang T, Chi H, Gao H. Omics-enhanced nanomedicine: integrating multi-omics for precision cancer diagnosis and therapy. Discov Oncol. 2025;17(1):97.","journal-title":"Discov Oncol"},{"key":"1811_CR51","doi-asserted-by":"publisher","first-page":"102660","DOI":"10.1016\/j.mtbio.2025.102660","volume":"36","author":"A Younas","year":"2026","unstructured":"Younas A, Wang S, Asad M, Al Mamun A, Majeed S, Sharif A, Zhou Q, Liu Y, Geng P, Shao C, et al. Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics - pioneering a new era in precision oncology. Mater Today Bio. 2026;36:102660.","journal-title":"Mater Today Bio"},{"issue":"1","key":"1811_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41698-025-00857-1","volume":"9","author":"SY Jing","year":"2025","unstructured":"Jing SY, Wang HQ, Lin P, Yuan J, Tang ZX, Li H. Quantifying and interpreting biologically meaningful spatial signatures within tumor microenvironments. NPJ Precis Oncol. 2025;9(1):68.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"1811_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","volume":"18","author":"Q Hu","year":"2025","unstructured":"Hu Q, Zhu Y, Mei J, Liu Y, Zhou G. Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy. J Hematol Oncol. 2025;18(1):65.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1811_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/metabo15030201","volume":"15","author":"S Fan","year":"2025","unstructured":"Fan S, Wang W, Che W, Xu Y, Jin C, Dong L, Xia Q. Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI. Metabolites 2025;15(3):20","journal-title":"Metabolites"},{"issue":"1","key":"1811_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-025-01692-4","volume":"18","author":"N Liu","year":"2025","unstructured":"Liu N, Wang X, Wang Z, Kan Y, Fang Y, Gao J, Kong X, Wang J. Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy. J Hematol Oncol. 2025;18(1):45.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"1811_CR56","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.ymthe.2023.03.026","volume":"31","author":"Y Liu","year":"2023","unstructured":"Liu Y, Fei Y, Wang X, Yang B, Li M, Luo Z. Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity. Mol Ther. 2023;31(7):1938\u201359.","journal-title":"Mol Ther"},{"issue":"18","key":"1811_CR57","doi-asserted-by":"publisher","first-page":"10920","DOI":"10.1021\/acs.chemrev.3c00062","volume":"123","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Xiang J, Qiu N, Wang Y, Piao Y, Shao S, Tang J, Zhou Z, Shen Y. Tumor Abnormality-Oriented Nanomedicine Design. Chem Rev. 2023;123(18):10920\u201389.","journal-title":"Chem Rev"},{"key":"1811_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4\u201327.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8 Suppl 1","key":"1811_CR59","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/IJG.0000000000000108","volume":"23","author":"B Yue","year":"2014","unstructured":"Yue B. Biology of the extracellular matrix: an overview. J Glaucoma. 2014;23(8 Suppl 1):S20\u201323.","journal-title":"J Glaucoma"},{"issue":"1","key":"1811_CR60","doi-asserted-by":"publisher","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","volume":"4","author":"RO Hynes","year":"2012","unstructured":"Hynes RO, Naba A. Overview of the matrisome\u2013an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. 2012;4(1):a004903.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"24","key":"1811_CR61","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1111\/febs.15776","volume":"288","author":"NK Karamanos","year":"2021","unstructured":"Karamanos NK, Theocharis AD, Piperigkou Z, Manou D, Passi A, Skandalis SS, Vynios DH, Orian-Rousseau V, Ricard-Blum S, Schmelzer CEH, et al. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021;288(24):6850\u2013912.","journal-title":"FEBS J"},{"issue":"1","key":"1811_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/bph.14195","volume":"176","author":"JF Hastings","year":"2019","unstructured":"Hastings JF, Skhinas JN, Fey D, Croucher DR, Cox TR. The extracellular matrix as a key regulator of intracellular signalling networks. Br J Pharmacol. 2019;176(1):82\u201392.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"1811_CR63","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1811_CR64","doi-asserted-by":"crossref","unstructured":"Walker C, Mojares E, Del Rio Hernandez A. Role of Extracellular Matrix in Development and Cancer Progression. Int J Mol Sci 2018, 19(10).","DOI":"10.3390\/ijms19103028"},{"issue":"1","key":"1811_CR65","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120.","journal-title":"Nat Commun"},{"issue":"4","key":"1811_CR66","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196(4):395\u2013406.","journal-title":"J Cell Biol"},{"issue":"12","key":"1811_CR67","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243\u201353.","journal-title":"EMBO Rep"},{"key":"1811_CR68","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2015.08.017","volume":"219","author":"L Miao","year":"2015","unstructured":"Miao L, Lin CM, Huang L. Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. J Control Release. 2015;219:192\u2013204.","journal-title":"J Control Release"},{"key":"1811_CR69","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-319-16555-4_9","volume":"166","author":"L Miao","year":"2015","unstructured":"Miao L, Huang L. Exploring the tumor microenvironment with nanoparticles. Cancer Treat Res. 2015;166:193\u2013226.","journal-title":"Cancer Treat Res"},{"issue":"8","key":"1811_CR70","doi-asserted-by":"publisher","first-page":"7184","DOI":"10.1021\/acsnano.5c20618","volume":"20","author":"JE Hwang","year":"2026","unstructured":"Hwang JE, Jeon M, Yim H, Park J, Kim HS, Lee S, Park H, Lee JK, Im HJ. Collagenase-Functionalized Liposomes Overcome Stromal Barriers in Pancreatic Cancer. ACS Nano. 2026;20(8):7184\u2013204.","journal-title":"ACS Nano"},{"issue":"2","key":"1811_CR71","first-page":"265","volume":"2","author":"TT Goodman","year":"2007","unstructured":"Goodman TT, Olive PL, Pun SH. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomed. 2007;2(2):265\u201374.","journal-title":"Int J Nanomed"},{"key":"1811_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jconrel.2014.05.019","volume":"191","author":"AG Kohli","year":"2014","unstructured":"Kohli AG, Kivimae S, Tiffany MR, Szoka FC. Improving the distribution of Doxil(R) in the tumor matrix by depletion of tumor hyaluronan. J Control Release. 2014;191:105\u201314.","journal-title":"J Control Release"},{"issue":"10","key":"1811_CR73","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1021\/acsnano.9b02395","volume":"13","author":"A Zinger","year":"2019","unstructured":"Zinger A, Koren L, Adir O, Poley M, Alyan M, Yaari Z, Noor N, Krinsky N, Simon A, Gibori H, et al. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors. ACS Nano. 2019;13(10):11008\u201321.","journal-title":"ACS Nano"},{"issue":"1","key":"1811_CR74","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.1038\/s41598-017-10671-w","volume":"7","author":"MD Nieskoski","year":"2017","unstructured":"Nieskoski MD, Marra K, Gunn JR, Hoopes PJ, Doyley MM, Hasan T, Trembly BS, Pogue BW. Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer. Sci Rep. 2017;7(1):10093.","journal-title":"Sci Rep"},{"issue":"1","key":"1811_CR75","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1741-7015-4-38","volume":"4","author":"PP Provenzano","year":"2006","unstructured":"Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4(1):38.","journal-title":"BMC Med"},{"key":"1811_CR76","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL. Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance. Annu Rev Pathol. 2023;18:123\u201348.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1811_CR77","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","volume":"62","author":"MA Jacobetz","year":"2013","unstructured":"Jacobetz MA, Chan DS, Neesse A, Bapiro TE, Cook N, Frese KK, Feig C, Nakagawa T, Caldwell ME, Zecchini HI, et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 2013;62(1):112\u201320.","journal-title":"Gut"},{"key":"1811_CR78","doi-asserted-by":"crossref","unstructured":"Belhabib I, Zaghdoudi S, Lac C, Bousquet C, Jean C. Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy? Cancers (Basel) 2021, 13(14).","DOI":"10.3390\/cancers13143466"},{"issue":"3","key":"1811_CR79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1811_CR80","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/cancers7040902","volume":"7","author":"K Shiga","year":"2015","unstructured":"Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H. Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth. Cancers (Basel). 2015;7(4):2443\u201358.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1811_CR81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1042\/BST20160387","volume":"45","author":"B Erdogan","year":"2017","unstructured":"Erdogan B, Webb DJ. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans. 2017;45(1):229\u201336.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"1811_CR82","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D Ohlund","year":"2017","unstructured":"Ohlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"key":"1811_CR83","doi-asserted-by":"crossref","unstructured":"Vaish U, Jain T, Are AC, Dudeja V. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. Int J Mol Sci 2021, 22(24).","DOI":"10.3390\/ijms222413408"},{"issue":"1","key":"1811_CR84","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","volume":"9","author":"M Bartoschek","year":"2018","unstructured":"Bartoschek M, Oskolkov N, Bocci M, Lovrot J, Larsson C, Sommarin M, Madsen CD, Lindgren D, Pekar G, Karlsson G, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150.","journal-title":"Nat Commun"},{"issue":"3","key":"1811_CR85","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1042\/EBC20180050","volume":"63","author":"SD Vallet","year":"2019","unstructured":"Vallet SD, Ricard-Blum S. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. Essays Biochem. 2019;63(3):349\u201364.","journal-title":"Essays Biochem"},{"key":"1811_CR86","doi-asserted-by":"crossref","unstructured":"Wang TH, Hsia SM, Shieh TM. Lysyl Oxidase and the Tumor Microenvironment. Int J Mol Sci 2016, 18(1).","DOI":"10.3390\/ijms18010062"},{"issue":"8","key":"1811_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/biom10081093","volume":"10","author":"R Laczko","year":"2020","unstructured":"Laczko R, Csiszar K. Lysyl Oxidase (LOX): Functional Contributions to Signaling Pathways. Biomolecules. 2020;10(8):109.","journal-title":"Biomolecules"},{"issue":"5","key":"1811_CR88","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891\u2013906.","journal-title":"Cell"},{"issue":"1","key":"1811_CR89","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1247\/csf.11015","volume":"37","author":"T Nishioka","year":"2012","unstructured":"Nishioka T, Eustace A, West C. Lysyl oxidase: from basic science to future cancer treatment. Cell Struct Funct. 2012;37(1):75\u201380.","journal-title":"Cell Struct Funct"},{"issue":"22","key":"1811_CR90","doi-asserted-by":"publisher","first-page":"32100","DOI":"10.18632\/oncotarget.8527","volume":"7","author":"B Le Calve","year":"2016","unstructured":"Le Calve B, Griveau A, Vindrieux D, Marechal R, Wiel C, Svrcek M, Gout J, Azzi L, Payen L, Cros J, et al. Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution. Oncotarget. 2016;7(22):32100\u201312.","journal-title":"Oncotarget"},{"issue":"12","key":"1811_CR91","doi-asserted-by":"publisher","first-page":"e23538","DOI":"10.1002\/jcla.23538","volume":"34","author":"M Ye","year":"2020","unstructured":"Ye M, Zhou J, Gao Y, Pan S, Zhu X. The prognostic value of the lysyl oxidase family in ovarian cancer. J Clin Lab Anal. 2020;34(12):e23538.","journal-title":"J Clin Lab Anal"},{"key":"1811_CR92","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/OTT.S6909","volume":"3","author":"V Bolos","year":"2010","unstructured":"Bolos V, Gasent JM, Lopez-Tarruella S, Grande E. The dual kinase complex FAK-Src as a promising therapeutic target in cancer. Onco Targets Ther. 2010;3:83\u201397.","journal-title":"Onco Targets Ther"},{"key":"1811_CR93","doi-asserted-by":"crossref","unstructured":"Warren JSA, Xiao Y, Lamar JM. YAP\/TAZ Activation as a Target for Treating Metastatic Cancer. Cancers (Basel) 2018, 10(4).","DOI":"10.3390\/cancers10040115"},{"issue":"10","key":"1811_CR94","doi-asserted-by":"publisher","first-page":"R536","DOI":"10.1016\/j.cub.2021.01.038","volume":"31","author":"MR Chastney","year":"2021","unstructured":"Chastney MR, Conway JRW, Ivaska J. Integrin adhesion complexes. Curr Biol. 2021;31(10):R536\u201342.","journal-title":"Curr Biol"},{"issue":"119","key":"1811_CR95","doi-asserted-by":"publisher","first-page":"pe6","DOI":"10.1126\/stke.2002.119.pe6","volume":"2002","author":"FJ Alenghat","year":"2002","unstructured":"Alenghat FJ, Ingber DE. Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE. 2002;2002(119):pe6.","journal-title":"Sci STKE"},{"issue":"5430","key":"1811_CR96","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","volume":"285","author":"FG Giancotti","year":"1999","unstructured":"Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285(5430):1028\u201332.","journal-title":"Science"},{"issue":"3","key":"1811_CR97","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","volume":"93","author":"M Hidalgo","year":"2001","unstructured":"Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001;93(3):178\u201393.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1811_CR98","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.joca.2017.02.791","volume":"25","author":"CY Yang","year":"2017","unstructured":"Yang CY, Chanalaris A, Troeberg L. ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the \u2018usual suspects\u2019. Osteoarthritis Cartilage. 2017;25(7):1000\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"1811_CR99","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrc2459","volume":"8","author":"G Murphy","year":"2008","unstructured":"Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer. 2008;8(12):929\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1811_CR100","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3390\/cancers4041252","volume":"4","author":"S Kumar","year":"2012","unstructured":"Kumar S, Rao N, Ge R. Emerging Roles of ADAMTSs in Angiogenesis and Cancer. Cancers (Basel). 2012;4(4):1252\u201399.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1811_CR101","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/path.1400","volume":"200","author":"I Stamenkovic","year":"2003","unstructured":"Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol. 2003;200(4):448\u201364.","journal-title":"J Pathol"},{"issue":"2","key":"1811_CR102","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1582-4934.2005.tb00355.x","volume":"9","author":"JE Rundhaug","year":"2005","unstructured":"Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9(2):267\u201385.","journal-title":"J Cell Mol Med"},{"key":"1811_CR103","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.matbio.2018.06.002","volume":"71\u201372","author":"TJ Mead","year":"2018","unstructured":"Mead TJ, Apte SS. ADAMTS proteins in human disorders. Matrix Biol. 2018;71\u201372:225\u201339.","journal-title":"Matrix Biol"},{"issue":"2","key":"1811_CR104","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biochi.2007.08.008","volume":"90","author":"N Rocks","year":"2008","unstructured":"Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie. 2008;90(2):369\u201379.","journal-title":"Biochimie"},{"issue":"1","key":"1811_CR105","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12951-022-01311-1","volume":"20","author":"J Guo","year":"2022","unstructured":"Guo J, Zeng H, Shi X, Han T, Liu Y, Liu Y, Liu C, Qu D, Chen Y. A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion. J Nanobiotechnol. 2022;20(1):114.","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"1811_CR106","doi-asserted-by":"publisher","first-page":"eaaw6081","DOI":"10.1126\/sciadv.aaw6081","volume":"5","author":"K Sasaki","year":"2019","unstructured":"Sasaki K, Ishihara J, Ishihara A, Miura R, Mansurov A, Fukunaga K, Hubbell JA. Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy. Sci Adv. 2019;5(8):eaaw6081.","journal-title":"Sci Adv"},{"issue":"6","key":"1811_CR107","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1021\/nl301206p","volume":"12","author":"M Kanapathipillai","year":"2012","unstructured":"Kanapathipillai M, Mammoto A, Mammoto T, Kang JH, Jiang E, Ghosh K, Korin N, Gibbs A, Mannix R, Ingber DE. Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix. Nano Lett. 2012;12(6):3213\u20137.","journal-title":"Nano Lett"},{"issue":"1","key":"1811_CR108","first-page":"vdad021","volume":"5","author":"SF Svensson","year":"2023","unstructured":"Svensson SF, Halldorsson S, Latysheva A, Fuster-Garcia E, Hjornevik T, Fraser-Green J, Birkeland Bugge RA, Grinband J, Holm S, Sinkus R, et al. MR elastography identifies regions of extracellular matrix reorganization associated with shorter survival in glioblastoma patients. Neurooncol Adv. 2023;5(1):vdad021.","journal-title":"Neurooncol Adv"},{"issue":"22","key":"1811_CR109","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1016\/j.cell.2021.09.022","volume":"184","author":"BT Grunwald","year":"2021","unstructured":"Grunwald BT, Devisme A, Andrieux G, Vyas F, Aliar K, McCloskey CW, Macklin A, Jang GH, Denroche R, Romero JM, et al. Spatially confined sub-tumor microenvironments in pancreatic cancer. Cell. 2021;184(22):5577\u201392. e5518.","journal-title":"Cell"},{"issue":"3","key":"1811_CR110","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","volume":"178","author":"MW Conklin","year":"2011","unstructured":"Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 2011;178(3):1221\u201332.","journal-title":"Am J Pathol"},{"issue":"1","key":"1811_CR111","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","volume":"14","author":"R Arora","year":"2023","unstructured":"Arora R, Cao C, Kumar M, Sinha S, Chanda A, McNeil R, Samuel D, Arora RK, Matthews TW, Chandarana S, et al. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nat Commun. 2023;14(1):5029.","journal-title":"Nat Commun"},{"issue":"1","key":"1811_CR112","doi-asserted-by":"publisher","first-page":"e2209260120","DOI":"10.1073\/pnas.2209260120","volume":"120","author":"X He","year":"2023","unstructured":"He X, Yang Y, Han Y, Cao C, Zhang Z, Li L, Xiao C, Guo H, Wang L, Han L, et al. Extracellular matrix physical properties govern the diffusion of nanoparticles in tumor microenvironment. Proc Natl Acad Sci U S A. 2023;120(1):e2209260120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"1811_CR113","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","volume":"31","author":"RK Jain","year":"2013","unstructured":"Jain RK. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol. 2013;31(17):2205\u201318.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1811_CR114","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","volume":"160","author":"S Morikawa","year":"2002","unstructured":"Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol. 2002;160(3):985\u20131000.","journal-title":"Am J Pathol"},{"issue":"5","key":"1811_CR115","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/S0002-9440(10)63540-7","volume":"163","author":"P Baluk","year":"2003","unstructured":"Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol. 2003;163(5):1801\u201315.","journal-title":"Am J Pathol"},{"issue":"3","key":"1811_CR116","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","volume":"454","author":"S Reitsma","year":"2007","unstructured":"Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345\u201359.","journal-title":"Pflugers Arch"},{"issue":"1","key":"1811_CR117","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/joim.12465","volume":"280","author":"JM Tarbell","year":"2016","unstructured":"Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016;280(1):97\u2013113.","journal-title":"J Intern Med"},{"issue":"11","key":"1811_CR118","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653\u201364.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6976","key":"1811_CR119","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/427695a","volume":"427","author":"TP Padera","year":"2004","unstructured":"Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK. Pathology: cancer cells compress intratumour vessels. Nature. 2004;427(6976):695.","journal-title":"Nature"},{"issue":"1","key":"1811_CR120","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/med.21855","volume":"42","author":"S Rezzola","year":"2022","unstructured":"Rezzola S, Sigmund EC, Halin C, Ronca R. The lymphatic vasculature: An active and dynamic player in cancer progression. Med Res Rev. 2022;42(1):576\u2013614.","journal-title":"Med Res Rev"},{"key":"1811_CR121","doi-asserted-by":"publisher","first-page":"105493","DOI":"10.1016\/j.cmpb.2020.105493","volume":"193","author":"Y Gao","year":"2020","unstructured":"Gao Y, Shi Y, Fu M, Feng Y, Lin G, Kong D, Jiang B. Simulation study of the effects of interstitial fluid pressure and blood flow velocity on transvascular transport of nanoparticles in tumor microenvironment. Comput Methods Programs Biomed. 2020;193:105493.","journal-title":"Comput Methods Programs Biomed"},{"key":"1811_CR122","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","volume":"16","author":"RK Jain","year":"2014","unstructured":"Jain RK, Martin JD, Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng. 2014;16:321\u201346.","journal-title":"Annu Rev Biomed Eng"},{"issue":"6","key":"1811_CR123","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s10237-015-0682-0","volume":"14","author":"F Mpekris","year":"2015","unstructured":"Mpekris F, Angeli S, Pirentis AP, Stylianopoulos T. Stress-mediated progression of solid tumors: effect of mechanical stress on tissue oxygenation, cancer cell proliferation, and drug delivery. Biomech Model Mechanobiol. 2015;14(6):1391\u2013402.","journal-title":"Biomech Model Mechanobiol"},{"issue":"12","key":"1811_CR124","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrc.2017.93","volume":"17","author":"MW Dewhirst","year":"2017","unstructured":"Dewhirst MW, Secomb TW. Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer. 2017;17(12):738\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"1811_CR125","first-page":"6553","volume":"52","author":"M Leunig","year":"1992","unstructured":"Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, Jain RK. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res. 1992;52(23):6553\u201360.","journal-title":"Cancer Res"},{"issue":"1","key":"1811_CR126","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/mvre.1996.0041","volume":"52","author":"PA Netti","year":"1996","unstructured":"Netti PA, Roberge S, Boucher Y, Baxter LT, Jain RK. Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. Microvasc Res. 1996;52(1):27\u201346.","journal-title":"Microvasc Res"},{"key":"1811_CR127","doi-asserted-by":"publisher","first-page":"12240","DOI":"10.1038\/ncomms12240","volume":"7","author":"B Cruys","year":"2016","unstructured":"Cruys B, Wong BW, Kuchnio A, Verdegem D, Cantelmo AR, Conradi LC, Vandekeere S, Bouche A, Cornelissen I, Vinckier S, et al. Glycolytic regulation of cell rearrangement in angiogenesis. Nat Commun. 2016;7:12240.","journal-title":"Nat Commun"},{"key":"1811_CR128","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fcell.2020.00747","volume":"8","author":"N Clere","year":"2020","unstructured":"Clere N, Renault S, Corre I. Endothelial-to-Mesenchymal Transition in Cancer. Front Cell Dev Biol. 2020;8:747.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"1811_CR129","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","volume":"40","author":"Y Hua","year":"2022","unstructured":"Hua Y, Vella G, Rambow F, Allen E, Antoranz Martinez A, Duhamel M, Takeda A, Jalkanen S, Junius S, Smeets A, et al. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop. Cancer Cell. 2022;40(12):1600\u201318. e1610.","journal-title":"Cancer Cell"},{"key":"1811_CR130","doi-asserted-by":"publisher","first-page":"736670","DOI":"10.3389\/fimmu.2021.736670","volume":"12","author":"G Vella","year":"2021","unstructured":"Vella G, Guelfi S, Bergers G. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer. Front Immunol. 2021;12:736670.","journal-title":"Front Immunol"},{"issue":"4","key":"1811_CR131","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","volume":"180","author":"J Kalucka","year":"2020","unstructured":"Kalucka J, de Rooij L, Goveia J, Rohlenova K, Dumas SJ, Meta E, Conchinha NV, Taverna F, Teuwen LA, Veys K, et al. Single-Cell Transcriptome Atlas of Murine Endothelial Cells. Cell. 2020;180(4):764\u2013e779720.","journal-title":"Cell"},{"issue":"8","key":"1811_CR132","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","volume":"18","author":"N Ricard","year":"2021","unstructured":"Ricard N, Bailly S, Guignabert C, Simons M. The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy. Nat Rev Cardiol. 2021;18(8):565\u201380.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"1811_CR133","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12951-021-01180-0","volume":"19","author":"N Qi","year":"2021","unstructured":"Qi N, Zhang S, Zhou X, Duan W, Gao D, Feng J, Li A. Combined integrin alpha(v)beta(3) and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect. J Nanobiotechnol. 2021;19(1):446.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"1811_CR134","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.apsb.2020.08.013","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Huang C, Zhang L, Guo Q, Qin Y, Fan F, Li B, Xiao B, Zhu D, Zhang L. pH-sensitive and bubble-generating mesoporous silica-based nanoparticles for enhanced tumor combination therapy. Acta Pharm Sin B. 2021;11(2):520\u201333.","journal-title":"Acta Pharm Sin B"},{"key":"1811_CR135","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2017.12.026","volume":"271","author":"K Jiang","year":"2018","unstructured":"Jiang K, Song X, Yang L, Li L, Wan Z, Sun X, Gong T, Lin Q, Zhang Z. Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin. J Control Release. 2018;271:21\u201330.","journal-title":"J Control Release"},{"issue":"2","key":"1811_CR136","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.nano.2012.07.002","volume":"9","author":"S Torosean","year":"2013","unstructured":"Torosean S, Flynn B, Axelsson J, Gunn J, Samkoe KS, Hasan T, Doyley MM, Pogue BW. Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure. Nanomedicine. 2013;9(2):151\u20138.","journal-title":"Nanomedicine"},{"issue":"1","key":"1811_CR137","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jconrel.2013.08.296","volume":"172","author":"S Stapleton","year":"2013","unstructured":"Stapleton S, Allen C, Pintilie M, Jaffray DA. Tumor perfusion imaging predicts the intra-tumoral accumulation of liposomes. J Control Release. 2013;172(1):351\u20137.","journal-title":"J Control Release"},{"issue":"6","key":"1811_CR138","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nnano.2012.45","volume":"7","author":"VP Chauhan","year":"2012","unstructured":"Chauhan VP, Stylianopoulos T, Martin JD, Popovic Z, Chen O, Kamoun WS, Bawendi MG, Fukumura D, Jain RK. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol. 2012;7(6):383\u20138.","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"1811_CR139","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1021\/nl404391r","volume":"14","author":"S Kunjachan","year":"2014","unstructured":"Kunjachan S, Pola R, Gremse F, Theek B, Ehling J, Moeckel D, Hermanns-Sachweh B, Pechar M, Ulbrich K, Hennink WE, et al. Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines. Nano Lett. 2014;14(2):972\u201381.","journal-title":"Nano Lett"},{"issue":"13","key":"1811_CR140","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","volume":"66","author":"DB Kirpotin","year":"2006","unstructured":"Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 2006;66(13):6732\u201340.","journal-title":"Cancer Res"},{"key":"1811_CR141","doi-asserted-by":"publisher","first-page":"626229","DOI":"10.3389\/fcell.2021.626229","volume":"9","author":"M Tang","year":"2021","unstructured":"Tang M, Bolderson E, O\u2019Byrne KJ, Richard DJ. Tumor Hypoxia Drives Genomic Instability. Front Cell Dev Biol. 2021;9:626229.","journal-title":"Front Cell Dev Biol"},{"issue":"45","key":"1811_CR142","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1038\/onc.2016.119","volume":"35","author":"S Joshi","year":"2016","unstructured":"Joshi S, Kumar S, Ponnusamy MP, Batra SK. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival. Oncogene. 2016;35(45):5882\u201392.","journal-title":"Oncogene"},{"issue":"7","key":"1811_CR143","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1097\/MS9.0000000000003411","volume":"87","author":"EI Obeagu","year":"2025","unstructured":"Obeagu EI. Hypoxia-driven angiogenesis in breast cancer mechanisms and therapeutic targets: a narrative review. Ann Med Surg (Lond). 2025;87(7):4246\u201354.","journal-title":"Ann Med Surg (Lond)"},{"issue":"1093","key":"1811_CR144","first-page":"20170955","volume":"92","author":"VS Hughes","year":"2019","unstructured":"Hughes VS, Wiggins JM, Siemann DW. Tumor oxygenation and cancer therapy-then and now. Br J Radiol. 2019;92(1093):20170955.","journal-title":"Br J Radiol"},{"issue":"18","key":"1811_CR145","first-page":"5381","volume":"62","author":"DM McDonald","year":"2002","unstructured":"McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002;62(18):5381\u20135.","journal-title":"Cancer Res"},{"issue":"31","key":"1811_CR146","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41388-018-0259-3","volume":"37","author":"A Chen","year":"2018","unstructured":"Chen A, Sceneay J, Godde N, Kinwel T, Ham S, Thompson EW, Humbert PO, Moller A. Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene. 2018;37(31):4214\u201325.","journal-title":"Oncogene"},{"issue":"7","key":"1811_CR147","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/1078-0432.CCR-06-2971","volume":"13","author":"N Chaudary","year":"2007","unstructured":"Chaudary N, Hill RP. Hypoxia and metastasis. Clin Cancer Res. 2007;13(7):1947\u20139.","journal-title":"Clin Cancer Res"},{"key":"1811_CR148","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jconrel.2021.11.034","volume":"341","author":"N Filipczak","year":"2022","unstructured":"Filipczak N, Joshi U, Attia SA, Fridman IB, Cohen S, Konry T, Torchilin V. Hypoxia-sensitive drug delivery to tumors. J Controlled Release. 2022;341:431\u201342.","journal-title":"J Controlled Release"},{"key":"1811_CR149","first-page":"21","volume":"345","author":"Z Li","year":"2010","unstructured":"Li Z, Rich JN. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol. 2010;345:21\u201330.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"1811_CR150","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6(8):583\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"1811_CR151","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","volume":"99","author":"O Tredan","year":"2007","unstructured":"Tredan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007;99(19):1441\u201354.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1811_CR152","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"},{"key":"1811_CR153","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biomaterials.2017.10.014","volume":"150","author":"A Nicolas-Boluda","year":"2018","unstructured":"Nicolas-Boluda A, Silva AKA, Fournel S, Gazeau F. Physical oncology: New targets for nanomedicine. Biomaterials. 2018;150:87\u201399.","journal-title":"Biomaterials"},{"issue":"10","key":"1811_CR154","first-page":"e70700","volume":"16","author":"M Basheeruddin","year":"2024","unstructured":"Basheeruddin M, Qausain S. Hypoxia-Inducible Factor 1-Alpha (HIF-1alpha) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting. Cureus. 2024;16(10):e70700.","journal-title":"Cureus"},{"issue":"1","key":"1811_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","volume":"36","author":"JW Lee","year":"2004","unstructured":"Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 2004;36(1):1\u201312.","journal-title":"Exp Mol Med"},{"issue":"7","key":"1811_CR156","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1349-7006.2005.00065.x","volume":"96","author":"E Sasabe","year":"2005","unstructured":"Sasabe E, Tatemoto Y, Li D, Yamamoto T, Osaki T. Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci. 2005;96(7):394\u2013402.","journal-title":"Cancer Sci"},{"issue":"24","key":"1811_CR157","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","volume":"16","author":"X Lu","year":"2010","unstructured":"Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res. 2010;16(24):5928\u201335.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1811_CR158","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28.","journal-title":"Signal Transduct Target Ther"},{"key":"1811_CR159","doi-asserted-by":"publisher","first-page":"961637","DOI":"10.3389\/fonc.2022.961637","volume":"12","author":"G Chen","year":"2022","unstructured":"Chen G, Wu K, Li H, Xia D, He T. Role of hypoxia in the tumor microenvironment and targeted therapy. Front Oncol. 2022;12:961637.","journal-title":"Front Oncol"},{"issue":"9","key":"1811_CR160","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","volume":"52","author":"WS Lee","year":"2020","unstructured":"Lee WS, Yang H, Chon HJ, Kim C. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Exp Mol Med. 2020;52(9):1475\u201385.","journal-title":"Exp Mol Med"},{"issue":"4","key":"1811_CR161","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3892\/ol.2022.13489","volume":"24","author":"D Ribatti","year":"2022","unstructured":"Ribatti D. Immunosuppressive effects of vascular endothelial growth factor. Oncol Lett. 2022;24(4):369.","journal-title":"Oncol Lett"},{"key":"1811_CR162","doi-asserted-by":"crossref","unstructured":"Shi R, Liao C, Zhang Q. Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications. Cells 2021, 10(3).","DOI":"10.3390\/cells10030678"},{"key":"1811_CR163","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","volume":"10","author":"I Terren","year":"2019","unstructured":"Terren I, Orrantia A, Vitalle J, Zenarruzabeitia O, Borrego F. NK Cell Metabolism and Tumor Microenvironment. Front Immunol. 2019;10:2278.","journal-title":"Front Immunol"},{"key":"1811_CR164","doi-asserted-by":"crossref","unstructured":"Krzywinska E, Stockmann C. Hypoxia, Metabolism and Immune Cell Function. Biomedicines 2018, 6(2).","DOI":"10.3390\/biomedicines6020056"},{"key":"1811_CR165","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3389\/fimmu.2017.01625","volume":"8","author":"S Terry","year":"2017","unstructured":"Terry S, Buart S, Chouaib S. Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity. Front Immunol. 2017;8:1625.","journal-title":"Front Immunol"},{"issue":"8","key":"1811_CR166","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","volume":"56","author":"A Sattiraju","year":"2023","unstructured":"Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C, Ramakrishnan A, Shen L, Tsankov AM, Hambardzumyan D, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity. 2023;56(8):1825\u201343. e1826.","journal-title":"Immunity"},{"issue":"4","key":"1811_CR167","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0305-7372(03)00003-3","volume":"29","author":"AM Shannon","year":"2003","unstructured":"Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev. 2003;29(4):297\u2013307.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"1811_CR168","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11(6):393\u2013410.","journal-title":"Nat Rev Cancer"},{"key":"1811_CR169","doi-asserted-by":"publisher","first-page":"e934116","DOI":"10.12659\/MSM.934116","volume":"27","author":"W Bouleftour","year":"2021","unstructured":"Bouleftour W, Rowinski E, Louati S, Sotton S, Wozny AS, Moreno-Acosta P, Mery B, Rodriguez-Lafrasse C, Magne N. A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy. Med Sci Monit. 2021;27:e934116.","journal-title":"Med Sci Monit"},{"key":"1811_CR170","doi-asserted-by":"crossref","unstructured":"Larue L, Myrzakhmetov B, Ben-Mihoub A, Moussaron A, Thomas N, Arnoux P, Baros F, Vanderesse R, Acherar S, Frochot C. Fighting Hypoxia to Improve PDT. Pharmaceutics 2019, 12(4).","DOI":"10.3390\/ph12040163"},{"issue":"1","key":"1811_CR171","doi-asserted-by":"publisher","first-page":"e2302028","DOI":"10.1002\/adhm.202302028","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Yue Z, Tang M, Wang W, Sun Y, Sun T, Chen C. Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy. Adv Healthc Mater. 2024;13(1):e2302028.","journal-title":"Adv Healthc Mater"},{"issue":"48","key":"1811_CR172","doi-asserted-by":"publisher","first-page":"e2103978","DOI":"10.1002\/adma.202103978","volume":"33","author":"Y Wan","year":"2021","unstructured":"Wan Y, Fu LH, Li C, Lin J, Huang P. Conquering the Hypoxia Limitation for Photodynamic Therapy. Adv Mater. 2021;33(48):e2103978.","journal-title":"Adv Mater"},{"key":"1811_CR173","doi-asserted-by":"crossref","unstructured":"Belisario DC, Kopecka J, Pasino M, Akman M, De Smaele E, Donadelli M, Riganti C. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance. Cells 2020, 9(12).","DOI":"10.3390\/cells9122598"},{"issue":"3","key":"1811_CR174","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/imm.12917","volume":"154","author":"S Damgaci","year":"2018","unstructured":"Damgaci S, Ibrahim-Hashim A, Enriquez-Navas PM, Pilon-Thomas S, Guvenis A, Gillies RJ. Hypoxia and acidosis: immune suppressors and therapeutic targets. Immunology. 2018;154(3):354\u201362.","journal-title":"Immunology"},{"issue":"1","key":"1811_CR175","doi-asserted-by":"publisher","first-page":"19350","DOI":"10.1038\/s41598-021-98638-w","volume":"11","author":"M Soltani","year":"2021","unstructured":"Soltani M, Souri M, Moradi Kashkooli F. Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors. Sci Rep. 2021;11(1):19350.","journal-title":"Sci Rep"},{"issue":"18","key":"1811_CR176","doi-asserted-by":"publisher","first-page":"e2207608","DOI":"10.1002\/advs.202207608","volume":"10","author":"S Wang","year":"2023","unstructured":"Wang S, Zhou Z, Hu R, Dong M, Zhou X, Ren S, Zhang Y, Chen C, Huang R, Zhu M, et al. Metabolic Intervention Liposome Boosted Lung Cancer Radio-Immunotherapy via Hypoxia Amelioration and PD-L1 Restraint. Adv Sci (Weinh). 2023;10(18):e2207608.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"1811_CR177","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1021\/acs.nanolett.0c00757","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Ding J, Xu X, Shi R, Saw PE, Wang J, Chung S, Li W, Aljaeid BM, Lee RJ, et al. Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano Lett. 2020;20(7):4857\u201363.","journal-title":"Nano Lett"},{"key":"1811_CR178","doi-asserted-by":"publisher","first-page":"102373","DOI":"10.1016\/j.nano.2021.102373","volume":"34","author":"HS Budi","year":"2021","unstructured":"Budi HS, Izadi S, Timoshin A, Asl SH, Beyzai B, Ghaderpour A, Alian F, Eshaghi FS, Mousavi SM, Rafiee B, et al. Blockade of HIF-1alpha and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth. Nanomedicine. 2021;34:102373.","journal-title":"Nanomedicine"},{"issue":"5","key":"1811_CR179","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1054\/bjoc.2000.1325","volume":"83","author":"KI Wijffels","year":"2000","unstructured":"Wijffels KI, Kaanders JH, Rijken PF, Bussink J, van den Hoogen FJ, Marres HA, de Wilde PC, Raleigh JA, van der Kogel AJ. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br J Cancer. 2000;83(5):674\u201383.","journal-title":"Br J Cancer"},{"issue":"17","key":"1811_CR180","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-04-0289","volume":"64","author":"KL Bennewith","year":"2004","unstructured":"Bennewith KL, Durand RE. Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res. 2004;64(17):6183\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"1811_CR181","first-page":"76","volume":"1866","author":"C Michiels","year":"2016","unstructured":"Michiels C, Tellier C, Feron O. Cycling hypoxia: A key feature of the tumor microenvironment. Biochim Biophys Acta. 2016;1866(1):76\u201386.","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"1811_CR182","first-page":"7066","volume":"62","author":"JH Kaanders","year":"2002","unstructured":"Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 2002;62(23):7066\u201374.","journal-title":"Cancer Res"},{"issue":"3","key":"1811_CR183","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1158\/0008-5472.CAN-03-2073","volume":"64","author":"DJ Brat","year":"2004","unstructured":"Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Van Meir EG. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 2004;64(3):920\u20137.","journal-title":"Cancer Res"},{"issue":"6","key":"1811_CR184","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","volume":"65","author":"Y Rong","year":"2006","unstructured":"Rong Y, Durden DL, Van Meir EG, Brat DJ. Pseudopalisading\u2019 necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol. 2006;65(6):529\u201339.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1811_CR185","doi-asserted-by":"publisher","first-page":"1042835","DOI":"10.3389\/fimmu.2022.1042835","volume":"13","author":"H Sun","year":"2022","unstructured":"Sun H, Li Y, Zhang Y, Zhao X, Dong X, Guo Y, Mo J, Che N, Ban X, Li F, et al. The relevance between hypoxia-dependent spatial transcriptomics and the prognosis and efficacy of immunotherapy in claudin-low breast cancer. Front Immunol. 2022;13:1042835.","journal-title":"Front Immunol"},{"key":"1811_CR186","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer E, Pedersen SF. The Acidic Tumor Microenvironment as a Driver of Cancer. Annu Rev Physiol. 2020;82:103\u201326.","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"1811_CR187","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3109\/14756366.2016.1140753","volume":"31","author":"KO Alfarouk","year":"2016","unstructured":"Alfarouk KO. Tumor metabolism, cancer cell transporters, and microenvironmental resistance. J Enzyme Inhib Med Chem. 2016;31(6):859\u201366.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"1811_CR188","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fphys.2013.00400","volume":"4","author":"O Sedlakova","year":"2014","unstructured":"Sedlakova O, Svastova E, Takacova M, Kopacek J, Pastorek J, Pastorekova S. Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors. Front Physiol. 2014;4:400.","journal-title":"Front Physiol"},{"key":"1811_CR189","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphys.2013.00370","volume":"4","author":"M Damaghi","year":"2013","unstructured":"Damaghi M, Wojtkowiak JW, Gillies RJ. pH sensing and regulation in cancer. Front Physiol. 2013;4:370.","journal-title":"Front Physiol"},{"issue":"4","key":"1811_CR190","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40005-022-00573-z","volume":"52","author":"J Shinn","year":"2022","unstructured":"Shinn J, Kwon N, Lee SA, Lee Y. Smart pH-responsive nanomedicines for disease therapy. J Pharm Investig. 2022;52(4):427\u201341.","journal-title":"J Pharm Investig"},{"issue":"6","key":"1811_CR191","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/mp200292c","volume":"8","author":"JW Wojtkowiak","year":"2011","unstructured":"Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm. 2011;8(6):2032\u20138.","journal-title":"Mol Pharm"},{"issue":"1","key":"1811_CR192","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2867-13-89","volume":"13","author":"Y Kato","year":"2013","unstructured":"Kato Y, Ozawa S, Miyamoto C, Maehata Y, Suzuki A, Maeda T, Baba Y. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 2013;13(1):89.","journal-title":"Cancer Cell Int"},{"issue":"47","key":"1811_CR193","doi-asserted-by":"publisher","first-page":"27042","DOI":"10.1039\/D5NR02990B","volume":"17","author":"J Jiang","year":"2025","unstructured":"Jiang J, Jin L, Zhao Z, Gao P, Li M, Zheng X, Li F. Design and application of proton gradient-based pH-responsive nanomaterials in the tumor microenvironment. Nanoscale. 2025;17(47):27042\u201365.","journal-title":"Nanoscale"},{"issue":"1","key":"1811_CR194","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41467-017-00598-1","volume":"8","author":"J Jo","year":"2017","unstructured":"Jo J, Lee CH, Kopelman R, Wang X. In vivo quantitative imaging of tumor pH by nanosonophore assisted multispectral photoacoustic imaging. Nat Commun. 2017;8(1):471.","journal-title":"Nat Commun"},{"issue":"1","key":"1811_CR195","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.1038\/s41598-017-07609-7","volume":"7","author":"JU Rao","year":"2017","unstructured":"Rao JU, Coman D, Walsh JJ, Ali MM, Huang Y, Hyder F. Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH. Sci Rep. 2017;7(1):7865.","journal-title":"Sci Rep"},{"key":"1811_CR196","doi-asserted-by":"publisher","first-page":"120463","DOI":"10.1016\/j.biomaterials.2020.120463","volume":"267","author":"S Quader","year":"2021","unstructured":"Quader S, Liu X, Toh K, Su YL, Maity AR, Tao A, Paraiso WKD, Mochida Y, Kinoh H, Cabral H, et al. Supramolecularly enabled pH- triggered drug action at tumor microenvironment potentiates nanomedicine efficacy against glioblastoma. Biomaterials. 2021;267:120463.","journal-title":"Biomaterials"},{"key":"1811_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.12.011","volume":"330","author":"YI Park","year":"2021","unstructured":"Park YI, Kwon SH, Lee G, Motoyama K, Kim MW, Lin M, Niidome T, Choi JH, Lee R. pH-sensitive multi-drug liposomes targeting folate receptor beta for efficient treatment of non-small cell lung cancer. J Control Release. 2021;330:1\u201314.","journal-title":"J Control Release"},{"issue":"1","key":"1811_CR198","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12951-022-01383-z","volume":"20","author":"T Zhao","year":"2022","unstructured":"Zhao T, Liang C, Zhao Y, Xue X, Ma Z, Qi J, Shen H, Yang S, Zhang J, Jia Q, et al. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy. J Nanobiotechnol. 2022;20(1):177.","journal-title":"J Nanobiotechnol"},{"issue":"20","key":"1811_CR199","doi-asserted-by":"publisher","first-page":"22560","DOI":"10.1021\/acsami.0c03957","volume":"12","author":"W Ye","year":"2020","unstructured":"Ye W, Chen X, Li X, Liu Y, Jia F, Jin Q, Ji J. Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release. ACS Appl Mater Interfaces. 2020;12(20):22560\u201371.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"36","key":"1811_CR200","doi-asserted-by":"publisher","first-page":"30543","DOI":"10.1021\/acsami.7b10840","volume":"9","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Dang M, Tian Y, Zhu Y, Liu W, Tian W, Su Y, Ni Q, Xu C, Lu N, et al. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles. ACS Appl Mater Interfaces. 2017;9(36):30543\u201352.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1811_CR201","doi-asserted-by":"crossref","unstructured":"Verkhovskii RA, Ivanov AN, Lengert EV, Tulyakova KA, Shilyagina NY, Ermakov AV. Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy. Pharmaceutics 2023, 15(5).","DOI":"10.3390\/pharmaceutics15051566"},{"issue":"1\u20132","key":"1811_CR202","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10555-019-09782-9","volume":"38","author":"A Anemone","year":"2019","unstructured":"Anemone A, Consolino L, Arena F, Capozza M, Longo DL. Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH. Cancer Metastasis Rev. 2019;38(1\u20132):25\u201349.","journal-title":"Cancer Metastasis Rev"},{"key":"1811_CR203","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41565-026-02130-3","volume":"21","author":"S Ye","year":"2026","unstructured":"Ye S, Chen S, Basava V, Torres K, Zhao Y, Huang G, Chen M, Gao J. AND logic nanoparticle for precision immunotherapy of metastatic cancers. Nat Nanotechnol. 2026;21:606\u201316.","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"1811_CR204","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"4","key":"1811_CR205","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298\u2013306.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1811_CR206","first-page":"416","volume":"15","author":"Q He","year":"2020","unstructured":"He Q, Chen J, Yan J, Cai S, Xiong H, Liu Y, Peng D, Mo M, Liu Z. Tumor microenvironment responsive drug delivery systems. Asian J Pharm Sci. 2020;15(4):416\u201348.","journal-title":"Asian J Pharm Sci"},{"issue":"8","key":"1811_CR207","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41416-023-02361-4","volume":"129","author":"MM Wang","year":"2023","unstructured":"Wang MM, Coupland SE, Aittokallio T, Figueiredo CR. Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities. Br J Cancer. 2023;129(8):1212\u201324.","journal-title":"Br J Cancer"},{"issue":"1","key":"1811_CR208","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13(1):80.","journal-title":"Exp Hematol Oncol"},{"key":"1811_CR209","doi-asserted-by":"crossref","unstructured":"Shen J, Choi YL, Lee T, Kim H, Chae YK, Dulken BW, Bogdan S, Huang M, Fisher GA, Park S et al. Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types. J Immunother Cancer 2024, 12(2).","DOI":"10.1136\/jitc-2023-008339"},{"issue":"7791","key":"1811_CR210","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577(7791):561\u20135.","journal-title":"Nature"},{"issue":"11","key":"1811_CR211","doi-asserted-by":"publisher","first-page":"e0540","DOI":"10.1097\/HC9.0000000000000540","volume":"8","author":"F Marsh-Wakefield","year":"2024","unstructured":"Marsh-Wakefield F, Santhakumar C, Ferguson AL, Ashhurst TM, Shin JS, Guan FHX, Shields NJ, Platt BJ, Putri GH, Gupta R, et al. Spatial mapping of the HCC landscape identifies unique intratumoral perivascular-immune neighborhoods. Hepatol Commun. 2024;8(11):e0540.","journal-title":"Hepatol Commun"},{"issue":"45","key":"1811_CR212","doi-asserted-by":"publisher","first-page":"eabg9518","DOI":"10.1126\/sciadv.abg9518","volume":"7","author":"JW Opzoomer","year":"2021","unstructured":"Opzoomer JW, Anstee JE, Dean I, Hill EJ, Bouybayoune I, Caron J, Muliaditan T, Gordon P, Sosnowska D, Nuamah R, et al. Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression. Sci Adv. 2021;7(45):eabg9518.","journal-title":"Sci Adv"},{"issue":"18","key":"1811_CR213","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1073\/pnas.1103782108","volume":"108","author":"A McNally","year":"2011","unstructured":"McNally A, Hill GR, Sparwasser T, Thomas R, Steptoe RJ. CD4\u2009+\u2009CD25+ regulatory T cells control CD8\u2009+\u2009T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci U S A. 2011;108(18):7529\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1811_CR214","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao X, Wan YY. Intricacies of TGF-beta signaling in Treg and Th17 cell biology. Cell Mol Immunol. 2023;20(9):1002\u201322.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"1811_CR215","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007;204(6):1257\u201365.","journal-title":"J Exp Med"},{"issue":"1","key":"1811_CR216","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","volume":"120","author":"C Groth","year":"2019","unstructured":"Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, Umansky V. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer. 2019;120(1):16\u201325.","journal-title":"Br J Cancer"},{"key":"1811_CR217","doi-asserted-by":"publisher","first-page":"874589","DOI":"10.3389\/fimmu.2022.874589","volume":"13","author":"Y Pu","year":"2022","unstructured":"Pu Y, Ji Q. Tumor-Associated Macrophages Regulate PD-1\/PD-L1 Immunosuppression. Front Immunol. 2022;13:874589.","journal-title":"Front Immunol"},{"key":"1811_CR218","doi-asserted-by":"publisher","first-page":"1476565","DOI":"10.3389\/fimmu.2024.1476565","volume":"15","author":"J Cao","year":"2024","unstructured":"Cao J, Liu C. Mechanistic studies of tumor-associated macrophage immunotherapy. Front Immunol. 2024;15:1476565.","journal-title":"Front Immunol"},{"issue":"9","key":"1811_CR219","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1172\/JCI80004","volume":"125","author":"MW Teng","year":"2015","unstructured":"Teng MW, Galon J, Fridman WH, Smyth MJ. From mice to humans: developments in cancer immunoediting. J Clin Invest. 2015;125(9):3338\u201346.","journal-title":"J Clin Invest"},{"issue":"10","key":"1811_CR220","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.immuni.2023.09.004","volume":"56","author":"E Ghorani","year":"2023","unstructured":"Ghorani E, Swanton C, Quezada SA. Cancer cell-intrinsic mechanisms driving acquired immune tolerance. Immunity. 2023;56(10):2270\u201395.","journal-title":"Immunity"},{"issue":"10","key":"1811_CR221","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.1007\/s00432-023-04737-8","volume":"149","author":"A Kallingal","year":"2023","unstructured":"Kallingal A, Olszewski M, Maciejewska N, Brankiewicz W, Baginski M. Cancer immune escape: the role of antigen presentation machinery. J Cancer Res Clin Oncol. 2023;149(10):8131\u201341.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1811_CR222","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. Annu Rev Immunol. 2019;37:457\u201395.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"1811_CR223","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang CH, Qiu J, O\u2019Sullivan D, Buck MD, Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ, et al. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015;162(6):1229\u201341.","journal-title":"Cell"},{"issue":"1","key":"1811_CR224","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","volume":"7","author":"DE Kuczek","year":"2019","unstructured":"Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, Siersbaek MS, Simoes AMC, Roslind A, Engelholm LH, Noessner E, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7(1):68.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"1811_CR225","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, Peralta R, Wang Y, Wang Y, DePeaux K, et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol. 2021;22(2):205\u201315.","journal-title":"Nat Immunol"},{"issue":"2","key":"1811_CR226","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41590-022-01379-9","volume":"24","author":"PDA Vignali","year":"2023","unstructured":"Vignali PDA, DePeaux K, Watson MJ, Ye C, Ford BR, Lontos K, McGaa NK, Scharping NE, Menk AV, Robson SC, et al. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nat Immunol. 2023;24(2):267\u201379.","journal-title":"Nat Immunol"},{"issue":"1","key":"1811_CR227","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12885-022-09612-2","volume":"22","author":"EB Glass","year":"2022","unstructured":"Glass EB, Hoover AA, Bullock KK, Madden MZ, Reinfeld BI, Harris W, Parker D, Hufnagel DH, Crispens MA, Khabele D, et al. Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer. BMC Cancer. 2022;22(1):497.","journal-title":"BMC Cancer"},{"key":"1811_CR228","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2018.05.018","volume":"281","author":"W Ou","year":"2018","unstructured":"Ou W, Thapa RK, Jiang L, Soe ZC, Gautam M, Chang JH, Jeong JH, Ku SK, Choi HG, Yong CS, et al. Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy. J Control Release. 2018;281:84\u201396.","journal-title":"J Control Release"},{"issue":"1","key":"1811_CR229","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/jacs.9b11046","volume":"142","author":"L Zheng","year":"2020","unstructured":"Zheng L, Hu X, Wu H, Mo L, Xie S, Li J, Peng C, Xu S, Qiu L, Tan W. In Vivo Monocyte\/Macrophage-Hitchhiked Intratumoral Accumulation of Nanomedicines for Enhanced Tumor Therapy. J Am Chem Soc. 2020;142(1):382\u201391.","journal-title":"J Am Chem Soc"},{"issue":"16","key":"1811_CR230","doi-asserted-by":"publisher","first-page":"15542","DOI":"10.1021\/acsnano.3c02013","volume":"17","author":"Y Su","year":"2023","unstructured":"Su Y, Gao J, Dong X, Wheeler KA, Wang Z. Neutrophil-Mediated Delivery of Nanocrystal Drugs via Photoinduced Inflammation Enhances Cancer Therapy. ACS Nano. 2023;17(16):15542\u201355.","journal-title":"ACS Nano"},{"issue":"4","key":"1811_CR231","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.trecan.2018.02.005","volume":"4","author":"T Stylianopoulos","year":"2018","unstructured":"Stylianopoulos T, Munn LL, Jain RK. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. Trends Cancer. 2018;4(4):292\u2013319.","journal-title":"Trends Cancer"},{"key":"1811_CR232","doi-asserted-by":"publisher","first-page":"103315","DOI":"10.1016\/j.ebiom.2021.103315","volume":"66","author":"K Chen","year":"2021","unstructured":"Chen K, Wang Q, Li M, Guo H, Liu W, Wang F, Tian X, Yang Y. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression. EBioMedicine. 2021;66:103315.","journal-title":"EBioMedicine"},{"issue":"1","key":"1811_CR233","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liang Y, Xu H, Zhang X, Mao T, Cui J, Yao J, Wang Y, Jiao F, Xiao X, et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 2021;7(1):36.","journal-title":"Cell Discov"},{"issue":"1","key":"1811_CR234","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1038\/s41467-023-40895-6","volume":"14","author":"K Oh","year":"2023","unstructured":"Oh K, Yoo YJ, Torre-Healy LA, Rao M, Fassler D, Wang P, Caponegro M, Gao M, Kim J, Sasson A, et al. Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype. Nat Commun. 2023;14(1):5226.","journal-title":"Nat Commun"},{"issue":"2","key":"1811_CR235","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","volume":"185","author":"T Risom","year":"2022","unstructured":"Risom T, Glass DR, Averbukh I, Liu CC, Baranski A, Kagel A, McCaffrey EF, Greenwald NF, Rivero-Gutierrez B, Strand SH, et al. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell. 2022;185(2):299\u2013310. e218.","journal-title":"Cell"},{"issue":"4","key":"1811_CR236","doi-asserted-by":"publisher","first-page":"101489","DOI":"10.1016\/j.xcrm.2024.101489","volume":"5","author":"Y Deng","year":"2024","unstructured":"Deng Y, Xia L, Zhang J, Deng S, Wang M, Wei S, Li K, Lai H, Yang Y, Bai Y, et al. Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages. Cell Rep Med. 2024;5(4):101489.","journal-title":"Cell Rep Med"},{"issue":"13","key":"1811_CR237","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","volume":"73","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos T, Martin JD, Snuderl M, Mpekris F, Jain SR, Jain RK. Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 2013;73(13):3833\u201341.","journal-title":"Cancer Res"},{"issue":"9","key":"1811_CR238","doi-asserted-by":"publisher","first-page":"E1142","DOI":"10.1073\/pnas.1521265113","volume":"113","author":"EA Sykes","year":"2016","unstructured":"Sykes EA, Dai Q, Sarsons CD, Chen J, Rocheleau JV, Hwang DM, Zheng G, Cramb DT, Rinker KD, Chan WC. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc Natl Acad Sci U S A. 2016;113(9):E1142\u20131151.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1811_CR239","doi-asserted-by":"publisher","first-page":"1802070","DOI":"10.1002\/advs.201802070","volume":"6","author":"Y Chen","year":"2019","unstructured":"Chen Y, Liu X, Yuan H, Yang Z, von Roemeling CA, Qie Y, Zhao H, Wang Y, Jiang W, Kim BYS. Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery. Adv Sci (Weinh). 2019;6(5):1802070.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1811_CR240","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tips.2017.10.009","volume":"39","author":"Q Chen","year":"2018","unstructured":"Chen Q, Liu G, Liu S, Su H, Wang Y, Li J, Luo C. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics. Trends Pharmacol Sci. 2018;39(1):59\u201374.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"1811_CR241","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","volume":"25","author":"F Klemm","year":"2015","unstructured":"Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 2015;25(4):198\u2013213.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"1811_CR242","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.semradonc.2019.12.004","volume":"30","author":"AM Monjazeb","year":"2020","unstructured":"Monjazeb AM, Schalper KA, Villarroel-Espindola F, Nguyen A, Shiao SL, Young K. Effects of Radiation on the Tumor Microenvironment. Semin Radiat Oncol. 2020;30(2):145\u201357.","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"1811_CR243","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8(1):198.","journal-title":"Signal Transduct Target Ther"},{"key":"1811_CR244","doi-asserted-by":"publisher","first-page":"104745","DOI":"10.1016\/j.phrs.2020.104745","volume":"155","author":"B Farhood","year":"2020","unstructured":"Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Eleojo Musa A, Najafi M. TGF-beta in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res. 2020;155:104745.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1811_CR245","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1186\/s12967-023-04554-0","volume":"21","author":"Z Yu","year":"2023","unstructured":"Yu Z, Xu C, Song B, Zhang S, Chen C, Li C, Zhang S. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. J Transl Med. 2023;21(1):708.","journal-title":"J Transl Med"},{"issue":"7","key":"1811_CR246","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"Pt 3","key":"1811_CR247","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.semcancer.2022.02.011","volume":"86","author":"TJ Berg","year":"2022","unstructured":"Berg TJ, Pietras A. Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells. Semin Cancer Biol. 2022;86(Pt 3):846\u201356.","journal-title":"Semin Cancer Biol"},{"key":"1811_CR248","doi-asserted-by":"publisher","first-page":"281958","DOI":"10.1155\/2013\/281958","volume":"2013","author":"MJ Gough","year":"2013","unstructured":"Gough MJ, Young K, Crittenden M. The impact of the myeloid response to radiation therapy. Clin Dev Immunol. 2013;2013:281958.","journal-title":"Clin Dev Immunol"},{"key":"1811_CR249","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","volume":"81","author":"JD Martin","year":"2019","unstructured":"Martin JD, Seano G, Jain RK. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. Annu Rev Physiol. 2019;81:505\u201334.","journal-title":"Annu Rev Physiol"},{"key":"1811_CR250","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.addr.2017.07.007","volume":"119","author":"T Ojha","year":"2017","unstructured":"Ojha T, Pathak V, Shi Y, Hennink WE, Moonen CTW, Storm G, Kiessling F, Lammers T. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. Adv Drug Deliv Rev. 2017;119:44\u201360.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"1811_CR251","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41416-021-01330-z","volume":"125","author":"AL Magnussen","year":"2021","unstructured":"Magnussen AL, Mills IG. Vascular normalisation as the stepping stone into tumour microenvironment transformation. Br J Cancer. 2021;125(3):324\u201336.","journal-title":"Br J Cancer"},{"key":"1811_CR252","unstructured":"Shiau C, Cao J, Gregory MT, Gong D, Yin X, Cho JW, Wang PL, Su J, Wang S, Reeves JW et al. Therapy-associated remodeling of pancreatic cancer revealed by single-cell spatial transcriptomics and optimal transport analysis. bioRxiv 2023."},{"key":"1811_CR253","doi-asserted-by":"publisher","first-page":"216656","DOI":"10.1016\/j.canlet.2024.216656","volume":"585","author":"F Jia","year":"2024","unstructured":"Jia F, Sun S, Li J, Wang W, Huang H, Hu X, Pan S, Chen W, Shen L, Yao Y, et al. Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing. Cancer Lett. 2024;585:216656.","journal-title":"Cancer Lett"},{"issue":"5","key":"1811_CR254","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1021\/acscentsci.9b01299","volume":"6","author":"ZH Houston","year":"2020","unstructured":"Houston ZH, Bunt J, Chen KS, Puttick S, Howard CB, Fletcher NL, Fuchs AV, Cui J, Ju Y, Cowin G, et al. Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies. ACS Cent Sci. 2020;6(5):727\u201338.","journal-title":"ACS Cent Sci"},{"issue":"2","key":"1811_CR255","first-page":"1751","volume":"13","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song W, Shen L, Qiu N, Hu M, Liu Y, Liu Q, Huang L. Vasodilator Hydralazine Promotes Nanoparticle Penetration in Advanced Desmoplastic Tumors. ACS Nano. 2019;13(2):1751\u201363.","journal-title":"ACS Nano"},{"issue":"2","key":"1811_CR256","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.apsb.2024.12.016","volume":"15","author":"H Nie","year":"2025","unstructured":"Nie H, Huang R, Jiang G, Li W, Yang L, Zhang M, Qian M, Guo W, Ye T, Huang R. Modulating active targeting nanoparticle design according to tumor progressions. Acta Pharm Sin B. 2025;15(2):1143\u201358.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1811_CR257","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41467-025-56768-z","volume":"16","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Lin Q, Feng HY, Zhang Y, Lai X, Zhu MH, Wang J, Shi J, Huang Y, Zhang L, et al. A multistage drug delivery approach for colorectal primary tumors and lymph node metastases. Nat Commun. 2025;16(1):1439.","journal-title":"Nat Commun"},{"issue":"1","key":"1811_CR258","doi-asserted-by":"publisher","first-page":"9990","DOI":"10.1038\/s41467-024-54265-3","volume":"15","author":"X Shan","year":"2024","unstructured":"Shan X, Cai Y, Zhu B, Zhou L, Sun X, Xu X, Yin Q, Wang D, Li Y. Rational strategies for improving the efficiency of design and discovery of nanomedicines. Nat Commun. 2024;15(1):9990.","journal-title":"Nat Commun"},{"issue":"7","key":"1811_CR259","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1039\/c2cs15344k","volume":"41","author":"N Kamaly","year":"2012","unstructured":"Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;41(7):2971\u20133010.","journal-title":"Chem Soc Rev"},{"issue":"9","key":"1811_CR260","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","volume":"30","author":"AK Pearce","year":"2019","unstructured":"Pearce AK, O\u2019Reilly RK. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine. Bioconjug Chem. 2019;30(9):2300\u201311.","journal-title":"Bioconjug Chem"},{"issue":"12 Pt 1","key":"1811_CR261","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46(12 Pt 1):6387\u201392.","journal-title":"Cancer Res"},{"issue":"D1","key":"1811_CR262","doi-asserted-by":"publisher","first-page":"D138","DOI":"10.1093\/nar\/gkad965","volume":"52","author":"E Clough","year":"2024","unstructured":"Clough E, Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, et al. NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update. Nucleic Acids Res. 2024;52(D1):D138\u201344.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1811_CR263","doi-asserted-by":"publisher","first-page":"D387","DOI":"10.1093\/nar\/gkab1053","volume":"50","author":"K Katz","year":"2022","unstructured":"Katz K, Shutov O, Lapoint R, Kimelman M, Brister JR, O\u2019Sullivan C. The Sequence Read Archive: a decade more of explosive growth. Nucleic Acids Res. 2022;50(D1):D387\u201390.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1811_CR264","doi-asserted-by":"publisher","first-page":"D1502","DOI":"10.1093\/nar\/gkaa1062","volume":"49","author":"U Sarkans","year":"2021","unstructured":"Sarkans U, Fullgrabe A, Ali A, Athar A, Behrangi E, Diaz N, Fexova S, George N, Iqbal H, Kurri S, et al. From ArrayExpress to BioStudies. Nucleic Acids Res. 2021;49(D1):D1502\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1811_CR265","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41467-021-21254-9","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Hernandez K, Savage J, Li S, Miller D, Agrawal S, Ortuno F, Staudt LM, Heath A, Grossman RL. Uniform genomic data analysis in the NCI Genomic Data Commons. Nat Commun. 2021;12(1):1226.","journal-title":"Nat Commun"},{"issue":"4","key":"1811_CR266","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41592-025-02643-0","volume":"22","author":"I de Bruijn","year":"2025","unstructured":"de Bruijn I, Nikolov M, Lau C, Clayton A, Gibbs DL, Mitraka E, Pozhidayeva D, Lash A, Sumer SO, Altreuter J, et al. Sharing data from the Human Tumor Atlas Network through standards, infrastructure and community engagement. Nat Methods. 2025;22(4):664\u201371.","journal-title":"Nat Methods"},{"issue":"D1","key":"1811_CR267","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gkae1142","volume":"53","author":"CZICS Program","year":"2025","unstructured":"Program CZICS, Abdulla S, Aevermann B, Assis P, Badajoz S, Bell SM, Bezzi E, Cakir B, Chaffer J, Chambers S, et al. CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data. Nucleic Acids Res. 2025;53(D1):D886\u2013900.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1811_CR268","doi-asserted-by":"publisher","first-page":"D1053","DOI":"10.1093\/nar\/gkad933","volume":"52","author":"Z Xu","year":"2024","unstructured":"Xu Z, Wang W, Yang T, Li L, Ma X, Chen J, Wang J, Huang Y, Gould J, Lu H, et al. STOmicsDB: a comprehensive database for spatial transcriptomics data sharing, analysis and visualization. Nucleic Acids Res. 2024;52(D1):D1053\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"1811_CR269","doi-asserted-by":"publisher","first-page":"114392","DOI":"10.1016\/j.celrep.2024.114392","volume":"43","author":"C Quek","year":"2024","unstructured":"Quek C, Pratapa A, Bai X, Al-Eryani G, Pires da Silva I, Mayer A, Bartonicek N, Harvey K, Maher NG, Conway JW, et al. Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy. Cell Rep. 2024;43(7):114392.","journal-title":"Cell Rep"},{"issue":"6574","key":"1811_CR270","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, Ren X, Wang L, Wu X, Zhang J, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374(6574):abe6474.","journal-title":"Science"},{"issue":"8","key":"1811_CR271","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41576-023-00580-2","volume":"24","author":"K Vandereyken","year":"2023","unstructured":"Vandereyken K, Sifrim A, Thienpont B, Voet T. Methods and applications for single-cell and spatial multi-omics. Nat Rev Genet. 2023;24(8):494\u2013515.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"1811_CR272","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","volume":"22","author":"SK Longo","year":"2021","unstructured":"Longo SK, Guo MG, Ji AL, Khavari PA. Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet. 2021;22(10):627\u201344.","journal-title":"Nat Rev Genet"},{"issue":"7871","key":"1811_CR273","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","volume":"596","author":"A Rao","year":"2021","unstructured":"Rao A, Barkley D, Franca GS, Yanai I. Exploring tissue architecture using spatial transcriptomics. Nature. 2021;596(7871):211\u201320.","journal-title":"Nature"},{"issue":"2","key":"1811_CR274","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41592-021-01065-y","volume":"18","author":"V Marx","year":"2021","unstructured":"Marx V. Publisher Correction: Method of the Year: spatially resolved transcriptomics. Nat Methods. 2021;18(2):219.","journal-title":"Nat Methods"},{"issue":"1","key":"1811_CR275","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick A, Shelansky R, Gottscho AD, Wagner F, Williams SR, Rouault M, Beliakoff G, Morrison CA, Oliveira MF, Sicherman JT, et al. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat Commun. 2023;14(1):8353.","journal-title":"Nat Commun"},{"issue":"1","key":"1811_CR276","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-pathmechdis-111523-023417","volume":"20","author":"TM Pentimalli","year":"2025","unstructured":"Pentimalli TM, Karaiskos N, Rajewsky N. Challenges and Opportunities in the Clinical Translation of High-Resolution Spatial Transcriptomics. Annu Rev Pathol. 2025;20(1):405\u201332.","journal-title":"Annu Rev Pathol"},{"key":"1811_CR277","unstructured":"10x Genomics. Atera: High Throughput. Whole Transcriptome. Single Cell Sensitivity. https:\/\/www.10xgenomics.com\/platforms\/atera"},{"key":"1811_CR278","unstructured":"Corporation B. Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026. In.: Bruker Corporation; 2026."},{"issue":"31","key":"1811_CR279","doi-asserted-by":"publisher","first-page":"e2505789122","DOI":"10.1073\/pnas.2505789122","volume":"122","author":"P Chen","year":"2025","unstructured":"Chen P, Geng H, Ma B, Zhang Y, Zhu Z, Li M, Chen S, Wang X, Sun C. Integrating spatial omics and single-cell mass spectrometry imaging reveals tumor-host metabolic interplay in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2025;122(31):e2505789122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1811_CR280","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s42003-023-05006-7","volume":"6","author":"L Sokol","year":"2023","unstructured":"Sokol L, Cuypers A, Truong AK, Bouche A, Brepoels K, Souffreau J, Rohlenova K, Vinckier S, Schoonjans L, Eelen G, et al. Prioritization and functional validation of target genes from single-cell transcriptomics studies. Commun Biol. 2023;6(1):648.","journal-title":"Commun Biol"},{"issue":"10","key":"1811_CR281","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41576-020-0258-4","volume":"21","author":"C Buccitelli","year":"2020","unstructured":"Buccitelli C, Selbach M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020;21(10):630\u201344.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"1811_CR282","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"MF Oliveira","year":"2025","unstructured":"Oliveira MF, Romero JP, Chung M, Williams SR, Gottscho AD, Gupta A, Pilipauskas SE, Mohabbat S, Raman N, Sukovich DJ, et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat Genet. 2025;57(6):1512\u201323.","journal-title":"Nat Genet"},{"issue":"1","key":"1811_CR283","doi-asserted-by":"publisher","first-page":"10259","DOI":"10.1038\/s41467-024-54710-3","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng Y, Ma W, Zang Y, Guo Y, Li Y, Zhang Y, Dong X, Liu Y, Zhan X, Pan Z, et al. Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients. Nat Commun. 2024;15(1):10259.","journal-title":"Nat Commun"},{"issue":"13","key":"1811_CR284","doi-asserted-by":"publisher","first-page":"e1702858","DOI":"10.1002\/smll.201702858","volume":"14","author":"H Lu","year":"2018","unstructured":"Lu H, Stenzel MH. Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. Small. 2018;14(13):e1702858.","journal-title":"Small"},{"issue":"5","key":"1811_CR285","doi-asserted-by":"publisher","first-page":"e1892","DOI":"10.1002\/wnan.1892","volume":"15","author":"DK Zhao","year":"2023","unstructured":"Zhao DK, Liang J, Huang XY, Shen S, Wang J. Organoids technology for advancing the clinical translation of cancer nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(5):e1892.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"1811_CR286","doi-asserted-by":"publisher","first-page":"e2200415","DOI":"10.1002\/biot.202200415","volume":"18","author":"M Karimov","year":"2023","unstructured":"Karimov M, Scherer M, Franke H, Ewe A, Aigner A. Analysis of polymeric nanoparticle properties for siRNA\/DNA delivery in a tumor xenograft tissue slice air-liquid interface model. Biotechnol J. 2023;18(4):e2200415.","journal-title":"Biotechnol J"},{"issue":"1","key":"1811_CR287","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"2","key":"1811_CR288","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17(2):159\u201362.","journal-title":"Nat Methods"},{"issue":"7","key":"1811_CR289","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2022.02.015","volume":"185","author":"M Dhainaut","year":"2022","unstructured":"Dhainaut M, Rose SA, Akturk G, Wroblewska A, Nielsen SR, Park ES, Buckup M, Roudko V, Pia L, Sweeney R, et al. Spatial CRISPR genomics identifies regulators of the tumor microenvironment. Cell. 2022;185(7):1223\u2013e12391220.","journal-title":"Cell"},{"issue":"2","key":"1811_CR290","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.nano.2012.05.015","volume":"9","author":"DR Elias","year":"2013","unstructured":"Elias DR, Poloukhtine A, Popik V, Tsourkas A. Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine. 2013;9(2):194\u2013201.","journal-title":"Nanomedicine"},{"issue":"12","key":"1811_CR291","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"H Cabral","year":"2011","unstructured":"Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6(12):815\u201323.","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"1811_CR292","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bpj.2010.06.016","volume":"99","author":"T Stylianopoulos","year":"2010","unstructured":"Stylianopoulos T, Poh MZ, Insin N, Bawendi MG, Fukumura D, Munn LL, Jain RK. Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. Biophys J. 2010;99(5):1342\u20139.","journal-title":"Biophys J"},{"key":"1811_CR293","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.matbio.2015.09.003","volume":"49","author":"U Eckhard","year":"2016","unstructured":"Eckhard U, Huesgen PF, Schilling O, Bellac CL, Butler GS, Cox JH, Dufour A, Goebeler V, Kappelhoff R, Keller UAD, et al. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses. Matrix Biol. 2016;49:37\u201360.","journal-title":"Matrix Biol"},{"issue":"7Supplement","key":"1811_CR294","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1158\/1538-7445.AM2026-5450","volume":"86","author":"S Bae","year":"2026","unstructured":"Bae S, Park J, Choi JY, Lee D, Im H-J, Choi H. Decoding ADC payload dynamics with a spatial transcriptomics-integrated tumor microenvironment PK model. Cancer Res. 2026;86(7Supplement):5450\u20135450.","journal-title":"Cancer Res"},{"issue":"8","key":"1811_CR295","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1073\/pnas.1620874114","volume":"114","author":"JE Dahlman","year":"2017","unstructured":"Dahlman JE, Kauffman KJ, Xing Y, Shaw TE, Mir FF, Dlott CC, Langer R, Anderson DG, Wang ET. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc Natl Acad Sci U S A. 2017;114(8):2060\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"1811_CR296","doi-asserted-by":"publisher","first-page":"E9944","DOI":"10.1073\/pnas.1811276115","volume":"115","author":"CD Sago","year":"2018","unstructured":"Sago CD, Lokugamage MP, Paunovska K, Vanover DA, Monaco CM, Shah NN, Gamboa Castro M, Anderson SE, Rudoltz TG, Lando GN, et al. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing. Proc Natl Acad Sci U S A. 2018;115(42):E9944\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1811_CR297","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.7150\/thno.68000","volume":"12","author":"N Strittmatter","year":"2022","unstructured":"Strittmatter N, Moss JI, Race AM, Sutton D, Canales JR, Ling S, Wong E, Wilson J, Smith A, Howes C, et al. Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution. Theranostics. 2022;12(5):2162\u201374.","journal-title":"Theranostics"},{"issue":"3","key":"1811_CR298","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.7150\/thno.123973","volume":"16","author":"JY Park","year":"2026","unstructured":"Park JY, Choi J, Park J, Kim JS, Ann YC, Chung H, Park J, Kim J, Seok SH, Choi H, et al. Engineering and evaluation of precision-glycosylated clickable albumin nanoplatform for targeting the tumor microenvironment. Theranostics. 2026;16(3):1482\u2013503.","journal-title":"Theranostics"},{"issue":"2","key":"1811_CR299","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6282","key":"1811_CR300","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189\u201396.","journal-title":"Science"},{"issue":"1","key":"1811_CR301","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41467-024-55378-5","volume":"16","author":"B Alsaed","year":"2025","unstructured":"Alsaed B, Lin L, Son J, Li J, Smolander J, Lopez T, Eser PO, Ogino A, Ambrogio C, Eum Y, et al. Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment. Nat Commun. 2025;16(1):28.","journal-title":"Nat Commun"},{"issue":"8","key":"1811_CR302","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, Bassez A, Decaluwe H, Pircher A, Van den Eynde K, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277\u201389.","journal-title":"Nat Med"},{"issue":"1","key":"1811_CR303","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and Biology of Cancer-Associated Fibroblasts. Physiol Rev. 2021;101(1):147\u201376.","journal-title":"Physiol Rev"},{"issue":"2","key":"1811_CR304","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","volume":"84","author":"C Li","year":"2024","unstructured":"Li C, Guo H, Zhai P, Yan M, Liu C, Wang X, Shi C, Li J, Tong T, Zhang Z, et al. Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8\u2009+\u2009T Cells. Cancer Res. 2024;84(2):258\u201375.","journal-title":"Cancer Res"},{"issue":"12","key":"1811_CR305","doi-asserted-by":"publisher","first-page":"e1515","DOI":"10.1002\/ctm2.1515","volume":"13","author":"C Chen","year":"2023","unstructured":"Chen C, Guo Q, Liu Y, Hou Q, Liao M, Guo Y, Zang Y, Wang F, Liu H, Luan X. Single-cell and spatial transcriptomics reveal POSTN+ cancer\u2010associated fibroblasts correlated with immune suppression and tumour progression in non\u2010small cell lung cancer. Clin Transl Med. 2023;13(12):e1515.","journal-title":"Clin Transl Med"},{"issue":"8","key":"1811_CR306","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/ijbs.108618","volume":"21","author":"Y Wu","year":"2025","unstructured":"Wu Y, Li S, Yu H, Zhang S, Yan L, Guan X, Xu W, Wang Z, Lv A, Tian X, et al. Integrative Single-Cell and Spatial Transcriptomics Analysis Reveals ECM-remodeling Cancer-associated Fibroblast-Derived POSTN as a Key Mediator in Pancreatic Ductal Adenocarcinoma Progression. Int J Biol Sci. 2025;21(8):3573\u201396.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1811_CR307","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1038\/s41467-024-53908-9","volume":"15","author":"A Forsthuber","year":"2024","unstructured":"Forsthuber A, Aschenbrenner B, Korosec A, Jacob T, Annusver K, Krajic N, Kholodniuk D, Frech S, Zhu S, Purkhauser K, et al. Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy. Nat Commun. 2024;15(1):9678.","journal-title":"Nat Commun"},{"issue":"1","key":"1811_CR308","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"C Ma","year":"2023","unstructured":"Ma C, Yang C, Peng A, Sun T, Ji X, Mi J, Wei L, Shen S, Feng Q. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer. 2023;22(1):170.","journal-title":"Mol Cancer"},{"issue":"1","key":"1811_CR309","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, Ding X, Bao R, Hong L, Jia W, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742.","journal-title":"Nat Commun"},{"issue":"26","key":"1811_CR310","doi-asserted-by":"publisher","first-page":"e2312169","DOI":"10.1002\/adma.202312169","volume":"36","author":"T Lammers","year":"2024","unstructured":"Lammers T. Nanomedicine Tumor Targeting. Adv Mater. 2024;36(26):e2312169.","journal-title":"Adv Mater"},{"issue":"10","key":"1811_CR311","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ccell.2024.09.001","volume":"42","author":"D Gong","year":"2024","unstructured":"Gong D, Arbesfeld-Qiu JM, Perrault E, Bae JW, Hwang WL. Spatial oncology: Translating contextual biology to the clinic. Cancer Cell. 2024;42(10):1653\u201375.","journal-title":"Cancer Cell"},{"issue":"1","key":"1811_CR312","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12951-025-03476-x","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, Jiang H, Zhao C, Lei Y, Liu S, Xu C, Chen X, Zheng D, Wu X, Lin X, et al. CXCL12-targeting siRNA nanoparticles alleviate immunosuppression and inhibit tumor progression in esophageal squamous cell carcinoma. J Nanobiotechnol. 2025;23(1):519.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1811_CR313","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12951-025-03684-5","volume":"23","author":"Q Yan","year":"2025","unstructured":"Yan Q, Gong L, Tan Z, Liu Z, Li X, Liang D, Yang J, Zhang K, Dai S, Wang J. Targeting tumor microenvironment with biomimetic nanovesicles for non-small cell lung cancer gene therapy. J Nanobiotechnol. 2025;23(1):624.","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"1811_CR314","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Mousa M, Nadukkandy AS, Franssens L, Alnaqbi H, Alshamsi FY, Safar HA, Carmeliet P. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat Rev Cancer. 2023;23(8):544\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1811_CR315","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2020.03.002","volume":"37","author":"J Goveia","year":"2020","unstructured":"Goveia J, Rohlenova K, Taverna F, Treps L, Conradi LC, Pircher A, Geldhof V, de Rooij L, Kalucka J, Sokol L, et al. An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates. Cancer Cell. 2020;37(3):421.","journal-title":"Cancer Cell"},{"issue":"1","key":"1811_CR316","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ni.1675","volume":"10","author":"M Pruenster","year":"2009","unstructured":"Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, Richmond A, Graham GJ, Segerer S, Nibbs RJ, et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol. 2009;10(1):101\u20138.","journal-title":"Nat Immunol"},{"issue":"1","key":"1811_CR317","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12915-017-0381-7","volume":"15","author":"A Thiriot","year":"2017","unstructured":"Thiriot A, Perdomo C, Cheng G, Novitzky-Basso I, McArdle S, Kishimoto JK, Barreiro O, Mazo I, Triboulet R, Ley K, et al. Differential DARC\/ACKR1 expression distinguishes venular from non-venular endothelial cells in murine tissues. BMC Biol. 2017;15(1):45.","journal-title":"BMC Biol"},{"issue":"2","key":"1811_CR318","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood.V88.2.667.bloodjournal882667","volume":"88","author":"AW Griffioen","year":"1996","unstructured":"Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood. 1996;88(2):667\u201373.","journal-title":"Blood"},{"issue":"1","key":"1811_CR319","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1096\/fj.14-250985","volume":"29","author":"H Huang","year":"2015","unstructured":"Huang H, Langenkamp E, Georganaki M, Loskog A, Fuchs PF, Dieterich LC, Kreuger J, Dimberg A. VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-kappaB-induced endothelial activation. FASEB J. 2015;29(1):227\u201338.","journal-title":"FASEB J"},{"issue":"2","key":"1811_CR320","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-020-00292-x","volume":"22","author":"E Armingol","year":"2021","unstructured":"Armingol E, Officer A, Harismendy O, Lewis NE. Deciphering cell-cell interactions and communication from gene expression. Nat Rev Genet. 2021;22(2):71\u201388.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"1811_CR321","doi-asserted-by":"publisher","first-page":"101420","DOI":"10.1016\/j.xcrm.2024.101420","volume":"5","author":"L Wang","year":"2024","unstructured":"Wang L, Guo W, Guo Z, Yu J, Tan J, Simons DL, Hu K, Liu X, Zhou Q, Zheng Y, et al. PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer. Cell Rep Med. 2024;5(2):101420.","journal-title":"Cell Rep Med"},{"issue":"1","key":"1811_CR322","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, Khan L, Bensler NP, Bose P, De Carvalho DD. TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun. 2018;9(1):4692.","journal-title":"Nat Commun"},{"issue":"9","key":"1811_CR323","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941\u201351.","journal-title":"Nat Biotechnol"},{"issue":"Pt A","key":"1811_CR324","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","volume":"244","author":"F Danhier","year":"2016","unstructured":"Danhier F. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 2016;244(Pt A):108\u201321.","journal-title":"J Control Release"},{"key":"1811_CR325","doi-asserted-by":"crossref","unstructured":"Sheth V, Wang L, Bhattacharya R, Mukherjee P, Wilhelm S. Strategies for Delivering Nanoparticles across Tumor Blood Vessels. Adv Funct Mater 2021, 31(8).","DOI":"10.1002\/adfm.202007363"},{"issue":"5","key":"1811_CR326","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani S, Syed AM, Ngai J, Kingston BR, Maiorino L, Rothschild J, MacMillan P, Zhang Y, Rajesh NU, Hoang T. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19(5):566\u201375.","journal-title":"Nat Mater"},{"issue":"9","key":"1811_CR327","doi-asserted-by":"publisher","first-page":"14080","DOI":"10.1021\/acsnano.1c04510","volume":"15","author":"BR Kingston","year":"2021","unstructured":"Kingston BR, Lin ZP, Ouyang B, MacMillan P, Ngai J, Syed AM, Sindhwani S, Chan WCW. Specific Endothelial Cells Govern Nanoparticle Entry into Solid Tumors. ACS Nano. 2021;15(9):14080\u201394.","journal-title":"ACS Nano"},{"issue":"8","key":"1811_CR328","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41422-023-00831-1","volume":"33","author":"L Wu","year":"2023","unstructured":"Wu L, Yan J, Bai Y, Chen F, Zou X, Xu J, Huang A, Hou L, Zhong Y, Jing Z, et al. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. Cell Res. 2023;33(8):585\u2013603.","journal-title":"Cell Res"},{"issue":"6","key":"1811_CR329","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1073\/pnas.1018382108","volume":"108","author":"C Wong","year":"2011","unstructured":"Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG, Fukumura D. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A. 2011;108(6):2426\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"1811_CR330","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.1522080113","volume":"113","author":"HJ Li","year":"2016","unstructured":"Li HJ, Du JZ, Du XJ, Xu CF, Sun CY, Wang HX, Cao ZT, Yang XZ, Zhu YH, Nie S, et al. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. Proc Natl Acad Sci U S A. 2016;113(15):4164\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1811_CR331","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1038\/s41467-024-54671-7","volume":"15","author":"Y Takano","year":"2024","unstructured":"Takano Y, Suzuki J, Nomura K, Fujii G, Zenkoh J, Kawai H, Kuze Y, Kashima Y, Nagasawa S, Nakamura Y, et al. Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development. Nat Commun. 2024;15(1):10637.","journal-title":"Nat Commun"},{"issue":"9","key":"1811_CR332","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1021\/acs.jproteome.4c00099","volume":"23","author":"JK Macdonald","year":"2024","unstructured":"Macdonald JK, Taylor HB, Wang M, Delacourt A, Edge C, Lewin DN, Kubota N, Fujiwara N, Rasha F, Marquez CA, et al. The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma. J Proteome Res. 2024;23(9):3791\u2013805.","journal-title":"J Proteome Res"},{"issue":"1","key":"1811_CR333","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/s41467-022-32988-5","volume":"13","author":"AP Amini","year":"2022","unstructured":"Amini AP, Kirkpatrick JD, Wang CS, Jaeger AM, Su S, Naranjo S, Zhong Q, Cabana CM, Jacks T, Bhatia SN. Multiscale profiling of protease activity in cancer. Nat Commun. 2022;13(1):5745.","journal-title":"Nat Commun"},{"issue":"8Supplement1","key":"1811_CR334","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1158\/1538-7445.AM2025-6259","volume":"85","author":"S Bae","year":"2025","unstructured":"Bae S, Choi M, Choi H, Lee D, Na KJ, Lee D. Spatial transcriptomics-driven in silico modeling of therapeutic effects of antibody-drug conjugates and their association with treatment response in lung adenocarcinoma. Cancer Res. 2025;85(8Supplement1):6259\u20136259.","journal-title":"Cancer Res"},{"issue":"3","key":"1811_CR335","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","volume":"21","author":"PP Provenzano","year":"2012","unstructured":"Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(3):418\u201329.","journal-title":"Cancer Cell"},{"issue":"5","key":"1811_CR336","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1021\/acs.nanolett.6b00820","volume":"16","author":"H Zhou","year":"2016","unstructured":"Zhou H, Fan Z, Deng J, Lemons PK, Arhontoulis DC, Bowne WB, Cheng H. Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy. Nano Lett. 2016;16(5):3268\u201377.","journal-title":"Nano Lett"},{"issue":"4","key":"1811_CR337","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.2017.74.9564","volume":"36","author":"SR Hingorani","year":"2018","unstructured":"Hingorani SR, Zheng L, Bullock AJ, Seery TE, Harris WP, Sigal DS, Braiteh F, Ritch PS, Zalupski MM, Bahary N, et al. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel\/Gemcitabine Versus Nab-Paclitaxel\/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma. J Clin Oncol. 2018;36(4):359\u201366.","journal-title":"J Clin Oncol"},{"issue":"27","key":"1811_CR338","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","volume":"38","author":"E Van Cutsem","year":"2020","unstructured":"Van Cutsem E, Tempero MA, Sigal D, Oh DY, Fazio N, Macarulla T, Hitre E, Hammel P, Hendifar AE, Bates SE, et al. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma. J Clin Oncol. 2020;38(27):3185\u201394.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1811_CR339","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP, Tattersall IW, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735\u201347.","journal-title":"Cancer Cell"},{"issue":"6","key":"1811_CR340","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC Ozdemir","year":"2014","unstructured":"Ozdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719\u201334.","journal-title":"Cancer Cell"},{"issue":"4","key":"1811_CR341","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen Y, Kim J, Yang S, Wang H, Wu CJ, Sugimoto H, LeBleu VS, Kalluri R. Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell. 2021;39(4):548\u2013e565546.","journal-title":"Cancer Cell"},{"issue":"30","key":"1811_CR342","doi-asserted-by":"publisher","first-page":"E3091","DOI":"10.1073\/pnas.1411679111","volume":"111","author":"JJ Lee","year":"2014","unstructured":"Lee JJ, Perera RM, Wang H, Wu DC, Liu XS, Han S, Fitamant J, Jones PD, Ghanta KS, Kawano S, et al. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc Natl Acad Sci U S A. 2014;111(30):E3091\u20133100.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1811_CR343","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","volume":"15","author":"KC Valkenburg","year":"2018","unstructured":"Valkenburg KC, de Groot AE, Pienta KJ. Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol. 2018;15(6):366\u201381.","journal-title":"Nat Rev Clin Oncol"},{"issue":"26","key":"1811_CR344","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.7150\/thno.38587","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu X, Jiang J, Meng H. Transcytosis - An effective targeting strategy that is complementary to EPR effect for pancreatic cancer nano drug delivery. Theranostics. 2019;9(26):8018\u201325.","journal-title":"Theranostics"},{"issue":"1","key":"1811_CR345","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1038\/s41467-024-52416-0","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Hu Y, Zhang X, Shi X, Parak WJ, Pich A. Transvascular transport of nanocarriers for tumor delivery. Nat Commun. 2024;15(1):8172.","journal-title":"Nat Commun"},{"key":"1811_CR346","first-page":"382","volume":"4","author":"AS Moody","year":"2021","unstructured":"Moody AS, Dayton PA, Zamboni WC. Imaging methods to evaluate tumor microenvironment factors affecting nanoparticle drug delivery and antitumor response. Cancer Drug Resist. 2021;4:382\u2013413.","journal-title":"Cancer Drug Resist"},{"issue":"9","key":"1811_CR347","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud JL, Houel A, Panouillot M, Riffard C, Dieu-Nosjean MC. Tertiary lymphoid structures in anticancer immunity. Nat Rev Cancer. 2024;24(9):629\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1811_CR348","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1038\/s41467-024-52153-4","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ye SY, He S, Chi DM, Wang XZ, Wen YF, Ma D, Nie RC, Xiang P, Zhou Y, et al. Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma. Nat Commun. 2024;15(1):7713.","journal-title":"Nat Commun"},{"issue":"8","key":"1811_CR349","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1021\/acsnano.2c09619","volume":"17","author":"Z Wen","year":"2023","unstructured":"Wen Z, Liu H, Qiao D, Chen H, Li L, Yang Z, Zhu C, Zeng Z, Chen Y, Liu L. Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma. ACS Nano. 2023;17(8):7194\u2013206.","journal-title":"ACS Nano"},{"key":"1811_CR350","doi-asserted-by":"publisher","first-page":"1369626","DOI":"10.3389\/fimmu.2024.1369626","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu Y, Yan G, Zhang G. Tertiary lymphoid structures in cancer: maturation and induction. Front Immunol. 2024;15:1369626.","journal-title":"Front Immunol"},{"issue":"11","key":"1811_CR351","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991\u20131003.","journal-title":"Nat Mater"},{"key":"1811_CR352","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2019.12.041","volume":"319","author":"R Kumari","year":"2020","unstructured":"Kumari R, Sunil D, Ningthoujam RS. Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review. J Control Release. 2020;319:135\u201356.","journal-title":"J Control Release"},{"key":"1811_CR353","doi-asserted-by":"crossref","unstructured":"Cheng L, Yu J, Hao T, Wang W, Wei M, Li G. Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment. Pharmaceutics 2023, 15(11).","DOI":"10.3390\/pharmaceutics15112622"},{"key":"1811_CR354","doi-asserted-by":"publisher","first-page":"102362","DOI":"10.1016\/j.cbpa.2023.102362","volume":"76","author":"M Planque","year":"2023","unstructured":"Planque M, Igelmann S, Ferreira Campos AM, Fendt SM. Spatial metabolomics principles and application to cancer research. Curr Opin Chem Biol. 2023;76:102362.","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"1811_CR355","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13058-025-02065-y","volume":"27","author":"A Corrado","year":"2025","unstructured":"Corrado A, Lorito N, Anemone A, Carella A, Villano D, Pirotta E, Gammaraccio F, Subbiani A, Bacci M, Dastru W, et al. In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer. Breast Cancer Res. 2025;27(1):112.","journal-title":"Breast Cancer Res"},{"key":"1811_CR356","doi-asserted-by":"crossref","unstructured":"AlSawaftah NM, Awad NS, Pitt WG, Husseini GA. pH-Responsive Nanocarriers in Cancer Therapy. Polym (Basel) 2022, 14(5).","DOI":"10.3390\/polym14050936"},{"issue":"1","key":"1811_CR357","doi-asserted-by":"publisher","first-page":"101920","DOI":"10.1016\/j.xcrm.2024.101920","volume":"6","author":"J Zhang","year":"2025","unstructured":"Zhang J, Pan T, Lee J, Goldberg S, King SA, Tang E, Hu Y, Chen L, Hoover A, Zhu L, et al. Enabling tumor-specific drug delivery by targeting the Warburg effect of cancer. Cell Rep Med. 2025;6(1):101920.","journal-title":"Cell Rep Med"},{"issue":"8","key":"1811_CR358","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.apsb.2021.01.017","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang C, Li G, Deng G, Zhang H, Sun Y, An F. Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy. Acta Pharm Sin B. 2021;11(8):2220\u201342.","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"1811_CR359","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.tips.2018.06.003","volume":"39","author":"Q Yao","year":"2018","unstructured":"Yao Q, Kou L, Tu Y, Zhu L. MMP-Responsive \u2018Smart\u2019 Drug Delivery and Tumor Targeting. Trends Pharmacol Sci. 2018;39(8):766\u201381.","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"1811_CR360","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1021\/acs.bioconjchem.3c00266","volume":"34","author":"C Zhang","year":"2023","unstructured":"Zhang C, Jiang G, Gao X. Matrix Metalloproteinase-Responsive Drug Delivery Systems. Bioconjug Chem. 2023;34(8):1349\u201365.","journal-title":"Bioconjug Chem"},{"issue":"3","key":"1811_CR361","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2(3):161\u201374.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1811_CR362","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52\u201367.","journal-title":"Cell"},{"issue":"1","key":"1811_CR363","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ijms23010146","volume":"23","author":"S Niland","year":"2021","unstructured":"Niland S, Riscanevo AX, Eble JA. Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. Int J Mol Sci. 2021;23(1):146.","journal-title":"Int J Mol Sci"},{"key":"1811_CR364","doi-asserted-by":"crossref","unstructured":"Song X, Xiong A, Wu F, Li X, Wang J, Jiang T, Chen P, Zhang X, Zhao Z, Liu H et al. Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody. J Immunother Cancer 2023, 11(2).","DOI":"10.1136\/jitc-2022-006234"},{"key":"1811_CR365","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-cancerbio-030617-050549","volume":"2","author":"JS Dudani","year":"2018","unstructured":"Dudani JS, Warren AD, Bhatia SN. Harnessing protease activity to improve cancer care. Annu Rev Cancer Biol. 2018;2:353\u201376.","journal-title":"Annu Rev Cancer Biol"},{"key":"1811_CR366","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jconrel.2024.03.016","volume":"368","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Zhang Y, Liu C, Liu J, Xue W, Wang Z, Li X. Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy. J Control Release. 2024;368:663\u201375.","journal-title":"J Control Release"},{"issue":"12","key":"1811_CR367","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrc4027","volume":"15","author":"OC Olson","year":"2015","unstructured":"Olson OC, Joyce JA. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer. 2015;15(12):712\u201329.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1811_CR368","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1101\/gad.1874010","volume":"24","author":"V Gocheva","year":"2010","unstructured":"Gocheva V, Wang HW, Gadea BB, Shree T, Hunter KE, Garfall AL, Berman T, Joyce JA. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010;24(3):241\u201355.","journal-title":"Genes Dev"},{"key":"1811_CR369","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jconrel.2018.11.032","volume":"294","author":"MK Shim","year":"2019","unstructured":"Shim MK, Park J, Yoon HY, Lee S, Um W, Kim JH, Kang SW, Seo JW, Hyun SW, Park JH, et al. Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy. J Control Release. 2019;294:376\u201389.","journal-title":"J Control Release"},{"issue":"1","key":"1811_CR370","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12951-022-01762-6","volume":"21","author":"H Choi","year":"2023","unstructured":"Choi H, Yeo M, Kang Y, Kim HJ, Park SG, Jang E, Park SH, Kim E, Kang S. Lactate oxidase\/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth. J Nanobiotechnol. 2023;21(1):5.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1811_CR371","doi-asserted-by":"publisher","first-page":"1600124","DOI":"10.1002\/advs.201600124","volume":"4","author":"G Saravanakumar","year":"2017","unstructured":"Saravanakumar G, Kim J, Kim WJ. Reactive-Oxygen-Species-Responsive Drug Delivery Systems: Promises and Challenges. Adv Sci (Weinh). 2017;4(1):1600124.","journal-title":"Adv Sci (Weinh)"},{"key":"1811_CR372","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fphar.2018.00790","volume":"9","author":"S Hua","year":"2018","unstructured":"Hua S, de Matos MBC, Metselaar JM, Storm G. Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization. Front Pharmacol. 2018;9:790.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1811_CR373","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nchembio728","volume":"1","author":"G Blum","year":"2005","unstructured":"Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, Sloane BF, Bogyo M. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol. 2005;1(4):203\u20139.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"1811_CR374","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sinjab A, Min J, Han G, Paradiso F, Zhang Y, Wang R, Pei G, Dai Y, Liu Y, et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell. 2025;43(5):905\u201324. e906.","journal-title":"Cancer Cell"},{"issue":"4","key":"1811_CR375","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13(4):227\u201332.","journal-title":"Nat Rev Genet"},{"key":"1811_CR376","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1038\/srep05232","volume":"4","author":"S Hussain","year":"2014","unstructured":"Hussain S, Rodriguez-Fernandez M, Braun GB, Doyle FJ 3rd, Ruoslahti E. Quantity and accessibility for specific targeting of receptors in tumours. Sci Rep. 2014;4:5232.","journal-title":"Sci Rep"},{"issue":"3","key":"1811_CR377","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the Dependency of Cellular Protein Levels on mRNA Abundance. Cell. 2016;165(3):535\u201350.","journal-title":"Cell"},{"issue":"7926","key":"1811_CR378","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41586-022-05094-1","volume":"609","author":"Y Deng","year":"2022","unstructured":"Deng Y, Bartosovic M, Ma S, Zhang D, Kukanja P, Xiao Y, Su G, Liu Y, Qin X, Rosoklija GB, et al. Spatial profiling of chromatin accessibility in mouse and human tissues. Nature. 2022;609(7926):375\u201383.","journal-title":"Nature"},{"issue":"1","key":"1811_CR379","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1038\/s41467-023-40512-6","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Liu Y, Fields L, Shi X, Huang P, Lu H, Schneider AJ, Tang X, Puglielli L, Welham NV, et al. Single-cell lipidomics enabled by dual-polarity ionization and ion mobility-mass spectrometry imaging. Nat Commun. 2023;14(1):5185.","journal-title":"Nat Commun"},{"issue":"6","key":"1811_CR380","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/molecules28062712","volume":"28","author":"D Li","year":"2023","unstructured":"Li D, Ouyang Z, Ma X. Mass Spectrometry Imaging for Single-Cell or Subcellular Lipidomics: A Review of Recent Advancements and Future Development. Molecules. 2023;28(6):2712.","journal-title":"Molecules"},{"issue":"7955","key":"1811_CR381","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-023-05795-1","volume":"616","author":"D Zhang","year":"2023","unstructured":"Zhang D, Deng Y, Kukanja P, Agirre E, Bartosovic M, Dong M, Ma C, Ma S, Su G, Bao S, et al. Spatial epigenome-transcriptome co-profiling of mammalian tissues. Nature. 2023;616(7955):113\u201322.","journal-title":"Nature"},{"issue":"1","key":"1811_CR382","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-024-01596-9","volume":"17","author":"X Liu","year":"2024","unstructured":"Liu X, Peng T, Xu M, Lin S, Hu B, Chu T, Liu B, Xu Y, Ding W, Li L, et al. Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications. J Hematol Oncol. 2024;17(1):72.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1811_CR383","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria M, Bjornmalm M, Thurecht KJ, Kent SJ, Parton RG, Kavallaris M, Johnston APR, Gooding JJ, Corrie SR, Boyd BJ, et al. Minimum information reporting in bio-nano experimental literature. Nat Nanotechnol. 2018;13(9):777\u201385.","journal-title":"Nat Nanotechnol"},{"key":"1811_CR384","doi-asserted-by":"crossref","unstructured":"Baiao AR, Cai Z, Poulos RC, Robinson PJ, Reddel RR, Zhong Q, Vinga S, Goncalves E. A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches. Brief Bioinform 2025, 26(4).","DOI":"10.1093\/bib\/bbaf355"},{"issue":"9","key":"1811_CR385","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.tibtech.2020.02.013","volume":"38","author":"A Ma","year":"2020","unstructured":"Ma A, McDermaid A, Xu J, Chang Y, Ma Q. Integrative Methods and Practical Challenges for Single-Cell Multi-omics. Trends Biotechnol. 2020;38(9):1007\u201322.","journal-title":"Trends Biotechnol"},{"issue":"7","key":"1811_CR386","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41587-023-01935-0","volume":"42","author":"S Chen","year":"2024","unstructured":"Chen S, Zhu B, Huang S, Hickey JW, Lin KZ, Snyder M, Greenleaf WJ, Nolan GP, Zhang NR, Ma Z. Integration of spatial and single-cell data across modalities with weakly linked features. Nat Biotechnol. 2024;42(7):1096\u2013106.","journal-title":"Nat Biotechnol"},{"issue":"6657","key":"1811_CR387","doi-asserted-by":"publisher","first-page":"eabq4964","DOI":"10.1126\/science.abq4964","volume":"381","author":"D Bressan","year":"2023","unstructured":"Bressan D, Battistoni G, Hannon GJ. The dawn of spatial omics. Science. 2023;381(6657):eabq4964.","journal-title":"Science"},{"issue":"1","key":"1811_CR388","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet R, Arnol D, Bredikhin D, Deloro Y, Velten B, Marioni JC, Stegle O. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020;21(1):111.","journal-title":"Genome Biol"},{"key":"1811_CR389","unstructured":"Plummer JT, Dezem FS, Cook DP, Park J, Zhang L, Liu Y, Marcao M, DuBose H, Wani A, Wise K et al. Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets. Nat Biotechnol. 2025:1-13."},{"issue":"5","key":"1811_CR390","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41592-022-01409-2","volume":"19","author":"L Moses","year":"2022","unstructured":"Moses L, Pachter L. Museum of spatial transcriptomics. Nat Methods. 2022;19(5):534\u201346.","journal-title":"Nat Methods"},{"issue":"1","key":"1811_CR391","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13059-025-03624-4","volume":"26","author":"A Rademacher","year":"2025","unstructured":"Rademacher A, Huseynov A, Bortolomeazzi M, Wille SJ, Schumacher S, Sant P, Keitel D, Okonechnikov K, Ghasemi DR, Pajtler KW, et al. Comparison of spatial transcriptomics technologies using tumor cryosections. Genome Biol. 2025;26(1):176.","journal-title":"Genome Biol"},{"issue":"1","key":"1811_CR392","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gpb.2022.10.001","volume":"21","author":"S Fang","year":"2023","unstructured":"Fang S, Chen B, Zhang Y, Sun H, Liu L, Liu S, Li Y, Xu X. Computational Approaches and Challenges in Spatial Transcriptomics. Genomics Proteom Bioinf. 2023;21(1):24\u201347.","journal-title":"Genomics Proteom Bioinf"},{"issue":"1","key":"1811_CR393","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13059-025-03565-y","volume":"26","author":"A Salim","year":"2025","unstructured":"Salim A, Bhuva DD, Chen C, Tan CW, Yang P, Davis MJ, Yang JYH. SpaNorm: spatially-aware normalization for spatial transcriptomics data. Genome Biol. 2025;26(1):109.","journal-title":"Genome Biol"},{"issue":"1","key":"1811_CR394","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41592-024-02212-x","volume":"22","author":"L Marconato","year":"2025","unstructured":"Marconato L, Palla G, Yamauchi KA, Virshup I, Heidari E, Treis T, Vierdag WM, Toth M, Stockhaus S, Shrestha RB, et al. SpatialData: an open and universal data framework for spatial omics. Nat Methods. 2025;22(1):58\u201362.","journal-title":"Nat Methods"},{"issue":"2","key":"1811_CR395","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla G, Spitzer H, Klein M, Fischer D, Schaar AC, Kuemmerle LB, Rybakov S, Ibarra IL, Holmberg O, Virshup I, et al. Squidpy: a scalable framework for spatial omics analysis. Nat Methods. 2022;19(2):171\u20138.","journal-title":"Nat Methods"},{"issue":"1","key":"1811_CR396","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/17460441.2024.2430955","volume":"20","author":"Z Tanoli","year":"2025","unstructured":"Tanoli Z, Schulman A, Aittokallio T. Validation guidelines for drug-target prediction methods. Expert Opin Drug Discov. 2025;20(1):31\u201345.","journal-title":"Expert Opin Drug Discov"},{"issue":"16","key":"1811_CR397","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1039\/D5TB02390D","volume":"14","author":"M Zammit","year":"2026","unstructured":"Zammit M, Fleming J, Volk M. Receptor or rhetoric? a critical review of glucose transporter-targeting in nanomedicine. J Mater Chem B. 2026;14(16):4874\u2013902.","journal-title":"J Mater Chem B"},{"key":"1811_CR398","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biomaterials.2017.05.034","volume":"138","author":"SK Jones","year":"2017","unstructured":"Jones SK, Sarkar A, Feldmann DP, Hoffmann P, Merkel OM. Revisiting the value of competition assays in folate receptor-mediated drug delivery. Biomaterials. 2017;138:35\u201345.","journal-title":"Biomaterials"},{"issue":"3","key":"1811_CR399","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","volume":"16","author":"JJ Rennick","year":"2021","unstructured":"Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021;16(3):266\u201376.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"1811_CR400","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000538344","volume":"4","author":"KD Smith","year":"2024","unstructured":"Smith KD, Prince DK, MacDonald JW, Bammler TK, Akilesh S. Challenges and Opportunities for the Clinical Translation of Spatial Transcriptomics Technologies. Glomerular Dis. 2024;4(1):49\u201363.","journal-title":"Glomerular Dis"},{"issue":"7","key":"1811_CR401","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1038\/s41591-025-03715-6","volume":"31","author":"N Miglino","year":"2025","unstructured":"Miglino N, Toussaint NC, Ring A, Bonilla X, Tusup M, Gosztonyi B, Mehra T, Gut G, Jacob F, Chevrier S, et al. Feasibility of multiomics tumor profiling for guiding treatment of melanoma. Nat Med. 2025;31(7):2430\u201341.","journal-title":"Nat Med"},{"issue":"9","key":"1811_CR402","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ccell.2022.08.011","volume":"40","author":"D Akhoundova","year":"2022","unstructured":"Akhoundova D, Rubin MA. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future. Cancer Cell. 2022;40(9):920\u201338.","journal-title":"Cancer Cell"},{"issue":"1","key":"1811_CR403","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41698-024-00711-w","volume":"8","author":"CE Owens","year":"2024","unstructured":"Owens CE, Tan O, Kuroiwa-Trzmielina J, Shrestha RN, O\u2019Brien T, Tyrrell V, Schofield DJ. The economic costs of precision medicine for clinical translational research among children with high-risk cancer. NPJ Precis Oncol. 2024;8(1):224.","journal-title":"NPJ Precis Oncol"},{"key":"1811_CR404","unstructured":"U.S. Food and Drug Administration. Drug Products, Including Biological Products, that Contain Nanomaterials: Guidance for Industry. 2022. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/drug-products-including-biological-products-contain-nanomaterials-guidance-industry"},{"issue":"11","key":"1811_CR405","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1001\/jamaoncol.2016.2129","volume":"2","author":"M Schwaederle","year":"2016","unstructured":"Schwaederle M, Zhao M, Lee JJ, Lazar V, Leyland-Jones B, Schilsky RL, Mendelsohn J, Kurzrock R. Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis. JAMA Oncol. 2016;2(11):1452\u20139.","journal-title":"JAMA Oncol"},{"key":"1811_CR406","doi-asserted-by":"crossref","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA, editors. Jr. : Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. N Engl J Med 2018, 379(2):111\u2013121.","DOI":"10.1056\/NEJMoa1804710"},{"key":"1811_CR407","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","volume":"108","author":"JI Hare","year":"2017","unstructured":"Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Adv Drug Deliv Rev. 2017;108:25\u201338.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1811_CR408","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt CR, Ong GT, Church SE, Barker K, Danaher P, Geiss G, Hoang M, Jung J, Liang Y, McKay-Fleisch J, et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38(5):586\u201399.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1811_CR409","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","volume":"174","author":"Y Goltsev","year":"2018","unstructured":"Goltsev Y, Samusik N, Kennedy-Darling J, Bhate S, Hale M, Vazquez G, Black S, Nolan GP. Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging. Cell. 2018;174(4):968\u2013e981915.","journal-title":"Cell"},{"key":"1811_CR410","doi-asserted-by":"publisher","first-page":"687673","DOI":"10.3389\/fimmu.2021.687673","volume":"12","author":"D Phillips","year":"2021","unstructured":"Phillips D, Schurch CM, Khodadoust MS, Kim YH, Nolan GP, Jiang S. Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging. Front Immunol. 2021;12:687673.","journal-title":"Front Immunol"},{"key":"1811_CR411","unstructured":"U.S. Food and Drug Administration. Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and FDA Staff. 2013. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/distribution-in-vitro-diagnostic-products-labeled-research-use-only-or-investigational-use-only"},{"key":"1811_CR412","unstructured":"U.S. Food and Drug Administration. Laboratory Developed Tests. 2025. https:\/\/www.fda.gov\/medical-devices\/in-vitro-diagnostics\/laboratory-developed-tests"},{"issue":"2","key":"1811_CR413","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil(R)--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117\u201334.","journal-title":"J Control Release"},{"issue":"3","key":"1811_CR414","doi-asserted-by":"publisher","first-page":"e10246","DOI":"10.1002\/btm2.10246","volume":"6","author":"AC Anselmo","year":"2021","unstructured":"Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update post COVID-19 vaccines. Bioeng Transl Med. 2021;6(3):e10246.","journal-title":"Bioeng Transl Med"},{"issue":"4","key":"1811_CR415","first-page":"987","volume":"54","author":"A Gabizon","year":"1994","unstructured":"Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 1994;54(4):987\u201392.","journal-title":"Cancer Res"},{"issue":"1","key":"1811_CR416","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00280-011-1664-2","volume":"69","author":"NM La-Beck","year":"2012","unstructured":"La-Beck NM, Zamboni BA, Gabizon A, Schmeeda H, Amantea M, Gehrig PA, Zamboni WC. Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients. Cancer Chemother Pharmacol. 2012;69(1):43\u201350.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"1811_CR417","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 2012;14(2):282\u201395.","journal-title":"AAPS J"},{"issue":"7963","key":"1811_CR418","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas LA, Sethna Z, Soares KC, Olcese C, Pang N, Patterson E, Lihm J, Ceglia N, Guasp P, Chu A, et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature. 2023;618(7963):144\u201350.","journal-title":"Nature"},{"issue":"8056","key":"1811_CR419","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","volume":"639","author":"Z Sethna","year":"2025","unstructured":"Sethna Z, Guasp P, Reiche C, Milighetti M, Ceglia N, Patterson E, Lihm J, Payne G, Lyudovyk O, Rojas LA, et al. RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer. Nature. 2025;639(8056):1042\u201351.","journal-title":"Nature"},{"issue":"10427","key":"1811_CR420","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","volume":"403","author":"JS Weber","year":"2024","unstructured":"Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, et al. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study. Lancet. 2024;403(10427):632\u201344.","journal-title":"Lancet"},{"issue":"1","key":"1811_CR421","doi-asserted-by":"publisher","first-page":"e2500008","DOI":"10.1200\/OA-25-00008","volume":"3","author":"MS Carlino","year":"2026","unstructured":"Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, Faries M. Three-Year Update of a Randomized Phase IIb Study of the Individualized Neoantigen Therapy Intismeran Autogene (mRNA-4157, V940) Plus Pembrolizumab Versus Pembrolizumab in Resected Melanoma. JCO Oncol Adv. 2026;3(1):e2500008.","journal-title":"JCO Oncol Adv"},{"issue":"3","key":"1811_CR422","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","volume":"4","author":"P Zhang","year":"2023","unstructured":"Zhang P, Xiao Y, Sun X, Lin X, Koo S, Yaremenko AV, Qin D, Kong N, Farokhzad OC, Tao W. Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects. Med. 2023;4(3):147\u201367.","journal-title":"Med"},{"key":"1811_CR423","unstructured":"ClinicalTrials.gov. A study of the efficacy and safety of adjuvant autogene cevumeran plus atezolizumab and mFOLFIRINOX versus mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (IMCODE003). ClinicalTrials.gov identifier: NCT05968326. 2023. https:\/\/clinicaltrials.gov\/study\/NCT05968326"},{"key":"1811_CR424","unstructured":"ClinicalTrials.gov. A clinical study of intismeran autogene (V940) plus pembrolizumab in people with high-risk melanoma (V940-001). ClinicalTrials.gov identifier: NCT05933577. 2023. https:\/\/clinicaltrials.gov\/study\/NCT05933577"},{"issue":"6","key":"1811_CR425","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","volume":"18","author":"DB Doroshow","year":"2021","unstructured":"Doroshow DB, Bhalla S, Beasley MB, Sholl LM, Kerr KM, Gnjatic S, Wistuba II, Rimm DL, Tsao MS, Hirsch FR. PD-L1 as a biomarker of response to immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2021;18(6):345\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"1811_CR426","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/PAI.0000000000000408","volume":"24","author":"C Roach","year":"2016","unstructured":"Roach C, Zhang N, Corigliano E, Jansson M, Toland G, Ponto G, Dolled-Filhart M, Emancipator K, Stanforth D, Kulangara K. Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non-Small-cell Lung Cancer. Appl Immunohistochem Mol Morphol. 2016;24(6):392\u20137.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"1811_CR427","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5858\/arpa.2018-0043-OA","volume":"143","author":"K Kulangara","year":"2019","unstructured":"Kulangara K, Zhang N, Corigliano E, Guerrero L, Waldroup S, Jaiswal D, Ms MJ, Shah S, Hanks D, Wang J, et al. Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer. Arch Pathol Lab Med. 2019;143(3):330\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"10135","key":"1811_CR428","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pages","year":"2018","unstructured":"Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391(10135):2128\u201339.","journal-title":"Lancet"},{"issue":"4","key":"1811_CR429","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cac2.12023","volume":"40","author":"WCC Tan","year":"2020","unstructured":"Tan WCC, Nerurkar SN, Cai HY, Ng HHM, Wu D, Wee YTF, Lim JCT, Yeong J, Lim TKH. Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun (Lond). 2020;40(4):135\u201353.","journal-title":"Cancer Commun (Lond)"},{"issue":"17","key":"1811_CR430","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1200\/JCO.21.02010","volume":"40","author":"S Park","year":"2022","unstructured":"Park S, Ock C-Y, Kim H, Pereira S, Park S, Ma M, Choi S, Kim S, Shin S, Aum BJ. Artificial intelligence\u2013powered spatial analysis of tumor-infiltrating lymphocytes as complementary biomarker for immune checkpoint inhibition in non\u2013small-cell lung cancer. J Clin Oncol. 2022;40(17):1916\u201328.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1811_CR431","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, Albright A, Cheng JD, Kang SP, Shankaran V, et al. IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930\u201340.","journal-title":"J Clin Invest"},{"issue":"3","key":"1811_CR432","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","volume":"19","author":"LJ Jennings","year":"2017","unstructured":"Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, Temple-Smolkin RL, Voelkerding KV, Nikiforova MN. Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. J Mol Diagn. 2017;19(3):341\u201365.","journal-title":"J Mol Diagn"},{"key":"1811_CR433","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/978-1-60327-216-2_27","volume":"823","author":"LA Liotta","year":"2012","unstructured":"Liotta LA, Petricoin EF. 3rd: Regulatory approval pathways for molecular diagnostic technology. Methods Mol Biol. 2012;823:409\u201320.","journal-title":"Methods Mol Biol"},{"key":"1811_CR434","unstructured":"Food and Drug Administration. Medical Devices; Laboratory Developed Tests; Implementation of Vacatur. Fed Regist. 2025;90:45134\u201345136. https:\/\/www.federalregister.gov\/documents\/2025\/09\/19\/2025-18239\/regulation-identification-number-0910-aj05-medical-devices-laboratory-developed-tests-implementation"},{"key":"1811_CR435","unstructured":"American Clinical Laboratory Association v. U.S. Food and Drug Administration. No. 4:24-cv-00479-SDJ. E.D. Tex. 2025. https:\/\/documents.cap.org\/documents\/ldt-courtruling-03-31-2025.pdf"},{"issue":"6","key":"1811_CR436","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/cpt.955","volume":"103","author":"JT J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen JT, Hersom M. Clinical and regulatory aspects of companion diagnostic development in oncology. Clin Pharmacol Ther. 2018;103(6):999\u20131008.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1811_CR437","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.tranon.2021.101063","volume":"14","author":"JT Jorgensen","year":"2021","unstructured":"Jorgensen JT. The current landscape of the FDA approved companion diagnostics. Transl Oncol. 2021;14(6):101063.","journal-title":"Transl Oncol"},{"key":"1811_CR438","unstructured":"Food and Drug Administration. Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order; Request for Comments. Fed Regist. 2025;90:53261. https:\/\/www.federalregister.gov\/documents\/2025\/11\/25\/2025-21071\/immunology-and-microbiology-devices-reclassification-of-nucleic-acid-based-test-systems-for-use-with"},{"key":"1811_CR439","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drup.2017.02.002","volume":"30","author":"JD Twomey","year":"2017","unstructured":"Twomey JD, Brahme NN, Zhang B. Drug-biomarker co-development in oncology\u2009\u2013\u200920 years and counting. Drug Resist Updat. 2017;30:48\u201362.","journal-title":"Drug Resist Updat"},{"issue":"3","key":"1811_CR440","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"S Dordevic","year":"2022","unstructured":"Dordevic S, Gonzalez MM, Conejos-Sanchez I, Carreira B, Pozzi S, Acurcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res. 2022;12(3):500\u201325.","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"1811_CR441","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s13346-020-00744-1","volume":"10","author":"MS Taha","year":"2020","unstructured":"Taha MS, Padmakumar S, Singh A, Amiji MM. Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation. Drug Deliv Transl Res. 2020;10(3):766\u201390.","journal-title":"Drug Deliv Transl Res"},{"issue":"18","key":"1811_CR442","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1158\/1078-0432.CCR-12-1414","volume":"18","author":"T Lammers","year":"2012","unstructured":"Lammers T, Rizzo LY, Storm G, Kiessling F. Personalized nanomedicine. Clin Cancer Res. 2012;18(18):4889\u201394.","journal-title":"Clin Cancer Res"},{"issue":"7662","key":"1811_CR443","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U Sahin","year":"2017","unstructured":"Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, Lower M, Bukur V, Tadmor AD, Luxemburger U, Schrors B, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547(7662):222\u20136.","journal-title":"Nature"},{"issue":"11","key":"1811_CR444","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783\u201392.","journal-title":"N Engl J Med"},{"issue":"12","key":"1811_CR445","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078\u201394.","journal-title":"Nat Rev Mater"},{"key":"1811_CR446","unstructured":"U.S. Food and Drug Administration. Summary Basis for Regulatory Action: SPIKEVAX. 2022. https:\/\/www.fda.gov\/media\/155931\/download"},{"key":"1811_CR447","unstructured":"U.S. Food and Drug Administration. Summary Basis for Regulatory Action: COMIRNATY. 2021. https:\/\/www.fda.gov\/media\/151733\/download"},{"issue":"4","key":"1811_CR448","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/amajethics.2019.347","volume":"21","author":"J Paradise","year":"2019","unstructured":"Paradise J. Regulating nanomedicine at the food and drug administration. AMA J Ethics. 2019;21(4):347\u201355.","journal-title":"AMA J Ethics"},{"key":"1811_CR449","unstructured":"U.S. Food and Drug Administration. In Vitro Companion Diagnostic Devices: Guidance for Industry and Food and Drug Administration Staff. 2014. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/in-vitro-companion-diagnostic-devices"},{"key":"1811_CR450","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","volume":"326","author":"M Germain","year":"2020","unstructured":"Germain M, Caputo F, Metcalfe S, Tosi G, Spring K, Aslund AKO, Pottier A, Schiffelers R, Ceccaldi A, Schmid R. Delivering the power of nanomedicine to patients today. J Control Release. 2020;326:164\u201371.","journal-title":"J Control Release"},{"issue":"1","key":"1811_CR451","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13073-022-01102-1","volume":"14","author":"E Fountzilas","year":"2022","unstructured":"Fountzilas E, Tsimberidou AM, Vo HH, Kurzrock R. Clinical trial design in the era of precision medicine. Genome Med. 2022;14(1):101.","journal-title":"Genome Med"},{"issue":"6","key":"1811_CR452","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1208\/s12248-016-9961-7","volume":"18","author":"H Havel","year":"2016","unstructured":"Havel H, Finch G, Strode P, Wolfgang M, Zale S, Bobe I, Youssoufian H, Peterson M, Liu M. Nanomedicines: From Bench to Bedside and Beyond. AAPS J. 2016;18(6):1373\u20138.","journal-title":"AAPS J"},{"issue":"10","key":"1811_CR453","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883\u201392.","journal-title":"N Engl J Med"},{"issue":"1","key":"1811_CR454","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, Sun T, Wei J. Liquid biopsy in cancer current: status, challenges and future prospects. Signal Transduct Target Ther. 2024;9(1):336.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1811_CR455","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","volume":"14","author":"JP O\u2019Connor","year":"2017","unstructured":"O\u2019Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14(3):169\u201386.","journal-title":"Nat Rev Clin Oncol"},{"key":"1811_CR456","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","volume":"144","author":"R Mohammadpour","year":"2019","unstructured":"Mohammadpour R, Dobrovolskaia MA, Cheney DL, Greish KF, Ghandehari H. Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications. Adv Drug Deliv Rev. 2019;144:112\u201332.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1811_CR457","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WC. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014.","journal-title":"Nat Rev Mater"},{"issue":"11","key":"1811_CR458","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","volume":"14","author":"R van der Meel","year":"2019","unstructured":"van der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJM, Lammers T. Smart cancer nanomedicine. Nat Nanotechnol. 2019;14(11):1007\u201317.","journal-title":"Nat Nanotechnol"},{"issue":"11","key":"1811_CR459","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/nmat4718","volume":"15","author":"KM Tsoi","year":"2016","unstructured":"Tsoi KM, MacParland SA, Ma XZ, Spetzler VN, Echeverri J, Ouyang B, Fadel SM, Sykes EA, Goldaracena N, Kaths JM, et al. Mechanism of hard-nanomaterial clearance by the liver. Nat Mater. 2016;15(11):1212\u201321.","journal-title":"Nat Mater"},{"issue":"1","key":"1811_CR460","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","volume":"112","author":"T Ishida","year":"2006","unstructured":"Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, Kiwada H. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release. 2006;112(1):15\u201325.","journal-title":"J Control Release"},{"issue":"3","key":"1811_CR461","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1021\/acs.chemrev.6b00073","volume":"117","author":"BR Smith","year":"2017","unstructured":"Smith BR, Gambhir SS. Nanomaterials for In Vivo Imaging. Chem Rev. 2017;117(3):901\u201386.","journal-title":"Chem Rev"},{"issue":"17","key":"1811_CR462","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.7150\/thno.77259","volume":"12","author":"HN Jung","year":"2022","unstructured":"Jung HN, Lee SY, Lee S, Youn H, Im HJ. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging. Theranostics. 2022;12(17):7509\u201331.","journal-title":"Theranostics"},{"issue":"19","key":"1811_CR463","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-15-1558","volume":"75","author":"CM Dawidczyk","year":"2015","unstructured":"Dawidczyk CM, Russell LM, Searson PC. Recommendations for Benchmarking Preclinical Studies of Nanomedicines. Cancer Res. 2015;75(19):4016\u201320.","journal-title":"Cancer Res"},{"issue":"3","key":"1811_CR464","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","volume":"153","author":"YH Bae","year":"2011","unstructured":"Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198\u2013205.","journal-title":"J Control Release"},{"issue":"1","key":"1811_CR465","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","volume":"163","author":"CP Day","year":"2015","unstructured":"Day CP, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell. 2015;163(1):39\u201353.","journal-title":"Cell"},{"issue":"4","key":"1811_CR466","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc.2016.140","volume":"17","author":"AT Byrne","year":"2017","unstructured":"Byrne AT, Alferez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinska E, Caldas C, Chang DK, et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017;17(4):254\u201368.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1811_CR467","first-page":"125","volume":"70","author":"JJH Park","year":"2020","unstructured":"Park JJH, Hsu G, Siden EG, Thorlund K, Mills EJ. An overview of precision oncology basket and umbrella trials for clinicians. CA Cancer J Clin. 2020;70(2):125\u201337.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1811_CR468","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","volume":"18","author":"V Marx","year":"2021","unstructured":"Marx V. Method of the Year: spatially resolved transcriptomics. Nat Methods. 2021;18(1):9\u201314.","journal-title":"Nat Methods"},{"issue":"7676","key":"1811_CR469","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature24286","volume":"550","author":"J Shendure","year":"2017","unstructured":"Shendure J, Balasubramanian S, Church GM, Gilbert W, Rogers J, Schloss JA, Waterston RH. DNA sequencing at 40: past, present and future. Nature. 2017;550(7676):345\u201353.","journal-title":"Nature"},{"issue":"1","key":"1811_CR470","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19(1):15.","journal-title":"Genome Biol"},{"issue":"2","key":"1811_CR471","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla G, Spitzer H, Klein M, Fischer D, Schaar AC, Kuemmerle LB, Rybakov S, Ibarra IL, Holmberg O, Virshup I. Squidpy: a scalable framework for spatial omics analysis. Nat Methods. 2022;19(2):171\u20138.","journal-title":"Nat Methods"},{"issue":"8","key":"1811_CR472","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41592-024-02201-0","volume":"21","author":"H Cui","year":"2024","unstructured":"Cui H, Wang C, Maan H, Pang K, Luo F, Duan N, Wang B. scGPT: toward building a foundation model for single-cell multi-omics using generative AI. Nat Methods. 2024;21(8):1470\u201380.","journal-title":"Nat Methods"},{"issue":"4","key":"1811_CR473","doi-asserted-by":"publisher","first-page":"e70010","DOI":"10.1002\/qub2.70010","volume":"13","author":"T Liu","year":"2025","unstructured":"Liu T, Hao M, Liu X, Zhao H. A perspective on developing foundation models for analyzing spatial transcriptomic data. Quant Biology. 2025;13(4):e70010.","journal-title":"Quant Biology"},{"key":"1811_CR474","doi-asserted-by":"crossref","unstructured":"Tejada-Lapuerta A, Schaar AC, Gutgesell R, Palla G, Halle L, Minaeva M, Vornholz L, Dony L, Drummer F, Richter T. Nicheformer: a foundation model for single-cell and spatial omics. Nat Methods 2025:1\u201314.","DOI":"10.1038\/s41592-025-02814-z"},{"issue":"12","key":"1811_CR475","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/s41592-025-02899-6","volume":"22","author":"Q Blampey","year":"2025","unstructured":"Blampey Q, Benkirane H, Bercovici N, Mulder K, Gessain G, Ginhoux F, Andr\u00e9 F. Courn\u00e8de P-H: Novae: a graph-based foundation model for spatial transcriptomics data. Nat Methods. 2025;22(12):2539\u201350.","journal-title":"Nat Methods"},{"issue":"4","key":"1811_CR476","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.matt.2023.02.007","volume":"6","author":"RJ Hickman","year":"2023","unstructured":"Hickman RJ, Bannigan P, Bao Z, Aspuru-Guzik A, Allen C. Self-driving laboratories: A paradigm shift in nanomedicine development. Matter. 2023;6(4):1071\u201381.","journal-title":"Matter"},{"issue":"30","key":"1811_CR477","doi-asserted-by":"publisher","first-page":"e03138","DOI":"10.1002\/advs.202503138","volume":"12","author":"Q Wang","year":"2025","unstructured":"Wang Q, Liu Y, Li C, Xu B, Xu S, Liu B. Machine learning-enhanced nanoparticle design for precision cancer drug delivery. Adv Sci (Weinh). 2025;12(30):e03138.","journal-title":"Adv Sci (Weinh)"},{"key":"1811_CR478","doi-asserted-by":"publisher","first-page":"114138","DOI":"10.1016\/j.jconrel.2025.114138","volume":"386","author":"FM Kashkooli","year":"2025","unstructured":"Kashkooli FM, Bhandari A, Gu B, Kolios MC, Kohandel M, Zhan W. Multiphysics modelling enhanced by imaging and artificial intelligence for personalised cancer nanomedicine: Foundations for clinical digital twins. J Control Release. 2025;386:114138.","journal-title":"J Control Release"},{"issue":"1","key":"1811_CR479","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41524-021-00614-5","volume":"7","author":"NR Stillman","year":"2021","unstructured":"Stillman NR, Balaz I, Tsompanas M-A, Kovacevic M, Azimi S, Lafond S, Adamatzky A, Hauert S. Evolutionary computational platform for the automatic discovery of nanocarriers for cancer treatment. NPJ Comput Mater. 2021;7(1):150.","journal-title":"NPJ Comput Mater"},{"issue":"2","key":"1811_CR480","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10544-019-0380-2","volume":"21","author":"P Dogra","year":"2019","unstructured":"Dogra P, Butner JD, Chuang Y-l, Caserta S, Goel S, Brinker CJ, Cristini V, Wang Z. Mathematical modeling in cancer nanomedicine: a review. Biomed Microdevices. 2019;21(2):40.","journal-title":"Biomed Microdevices"},{"issue":"4","key":"1811_CR481","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng1201-365","volume":"29","author":"A Brazma","year":"2001","unstructured":"Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001;29(4):365\u201371.","journal-title":"Nat Genet"},{"issue":"36","key":"1811_CR482","doi-asserted-by":"publisher","first-page":"31933","DOI":"10.1021\/acsnano.5c12854","volume":"19","author":"CA Mirkin","year":"2025","unstructured":"Mirkin CA, Petrosko SH, Artzi N, Aydin K, Biaggne A, Brinker CJ, Bujold KE, Cao YC, Chan RR, Chen C. 33 Unresolved Questions in Nanoscience and Nanotechnology. ACS Nano. 2025;19(36):31933\u201368.","journal-title":"ACS Nano"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01811-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:02:04Z","timestamp":1787752924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-026-01811-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":482,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1811"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01811-9","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}